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Introduction: Preterm birth is increasing worldwide and is a major cause of neonatal death. 
Survivors are at increased risk of neurodisability, cognitive, social and psychiatric disorders in 
later life. Alterations to the white matter can be assessed using diffusion tensor imaging (DTI) 
MRI and are associated with poor neurodevelopmental outcome. The pathogenesis of white 
matter injury is multifactorial and several clinical risk and resilience factors have been 
identified. DNA methylation (DNAm) is an epigenetic process which links stressful early life 
experience to later life disease and is associated with normal brain development, neuronal 
processes and neurological disease. Several studies have shown DNAm is altered by the 
perinatal environment, however its role in preterm white mater injury is yet to be 
investigated.  
Aims: 1. To examine the relationship between preterm birth and white matter integrity 2. To 
investigate the effect of neuroprotective treatments and deleterious clinical states on white 
matter integrity in preterm infants 3. To assess the best DTI method of quantifying white 
matter integrity in a neonatal population 4. To investigate the effect of preterm birth on DNA 
methylation and 5. To determine the clinical and imaging factors that contribute to the 
variance in DNA Methylation caused by preterm birth  
Methods: DTI data was acquired from preterm infants (< 32 weeks’ gestation or < 1500 grams 
at birth) at term equivalent age (TEA) and term controls (> 37 weeks’ gestation at birth). 
Region-of-interests (ROI) and tract-averaged methods of DTI analysis were performed to 
obtain measurements of fractional anisotropy (FA) and mean diffusivity (MD) in the genu of 
corpus callosum, posterior limb of internal capsule and centrum semiovale. Clinical data was 
collected for all infants and the effect of prematurity, neuroprotective agents and clinical risk 
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factors on white matter integrity were analysed. 8 major white matter tracts were segmented 
using probabilistic neighbourhood tractography (PNT), a tract-averaged technique which also 
allowed the calculation of tract shape. The two DTI techniques were compared to evaluate 
agreement between results. DNA was collected from preterm infants and term controls at 
TEA, and a genome-wide analysis of DNAm was performed. DTI parameters from probabilistic 
neighborhood tractography (PNT) methodology and clinical risk and resilience factors were 
used to inform a principal components analysis to investigate the contribution of white 
matter integrity and clinical variables to variance in DNAm.  
Results: FA and MD were significantly affected by preterm birth on ROI analysis. In addition, 
DTI parameters were affected by clinical factors that included antenatal magnesium sulphate, 
histological chorioamnionitis and bronchopulmonary dysplasia. Evaluation of DTI 
methodology revealed good accuracy in repeated ROI measurements but limited agreement 
with tract-averaged values. Differential methylation was found within 25 gene bodies and 58 
promoters of protein-coding genes in preterm infants, compared with controls. 10 of these 
genes have a documented association with neural function or neurological disease. 
Differences detected in the array were validated with pyrosequencing which captured 
additional differentially methylated CpGs. Ninety-five percent of the variance in DNAm in 
preterm infants was explained by 23 principal components (PC); corticospinal tract shape 
associated with 6th PC, and gender and early nutritional exposure associated with the 7th PC.  
Conclusions: Preterm birth is associated with alterations in white matter integrity which is 
modifiable by clinical risk factors and neuroprotective agents. ROI analysis may not provide 
sufficient representation of white matter tracts in their entirety. Prematurity is related to 
alterations in the methylome at sites that influence neural development and function. 
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Differential methylation analysis has identified several promising candidate genes for future 





Introduction: Preterm birth, defined as being born less than 37 weeks’ gestation is increasing 
worldwide. Preterm infants are at increased risk of disability including cerebral palsy and 
problems with behavior, learning and mood in later life. A specialised imaging technique (DTI-
MRI) can assess the microscopic brain injury associated with preterm birth and results are 
linked to how an infant develops and learns. There are many underlying reasons which lead 
to brain injury in preterm infants but there are also ‘neuroprotective’ treatments which can 
improve brain development. DNA methylation (DNAm) is a genetic process which allows the 
environment we experience to alter how our genes are ‘read’ and therefore causes changes 
in how our bodies function. The role of DNAm in premature brain injury is yet to be 
investigated.  
Aims: To investigate the relationship between preterm birth and microscopic changes to 
specific regions of the brain and to investigate how neuroprotective treatments and harmful 
clinical experiences affect this. To assess two different methods of analysing DTI-MRI to 
determine which was preferable for use in newborn infants. To investigate the effect of 
preterm birth on DNA methylation and to determine if any clinical factors and microscopic 
brain changes will affect DNAm in preterm infants.   
Methods: Parental consent was given before enrolment in to the study. Preterm infants were 
defined as <32 weeks’ gestation or <1500g at birth, with term control infants being >37 weeks’ 
gestation. They underwent MRI imaging at term-equivalent age (between 38 and 42 weeks) 
and had saliva collected for DNA. Two methods (ROI and PNT) for assessing the brain white 
matter changes were used for analysis and their results were compared. DNAm was assessed 
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using a technique which looks at the entire genetic code. Statistical analysis was used to 
compare clinical factors and results from the PNT analysis with DNAm.  
Results: Preterm birth was negatively associated with microscopic changes in brain 
development, which also may be negatively affected by intrauterine infection or lung disease 
in the preterm infants but improved by an antenatal neuroprotective treatments - magnesium 
sulphate. When I compared two different DTI techniques they produced results with limited 
agreement and I concluded that PNT gave a better representation of the brain microscopic 
development.  DNA methylation was different between preterm infants and term controls in 
the middle of 25 genes and the starting sequence of 58 others.  10 of these genes have a 
documented association with brain function or disease. There was a subtle effect on DNAm 
from some clinical factors.  
Conclusions: Preterm birth is associated with microscopic changes to the brain which may be 
affected by infection, lung disease and the neuroprotective therapy – magnesium sulphate. 
PNT analysis may be preferable over ROI analysis to investigate the newborn brain. Preterm 
birth is related to changes in DNA methylation in several genes involved in brain development 
and function. This work has contributed to the understanding of preterm brain injury and may 





Chapter 1: Introduction 
 
1.1 Prematurity and Brain injury 
 
1.1.1 Definition, Incidence and Clinical burden of Preterm Birth 
 
Preterm birth, by definition being born at less than 37 weeks’ gestation, is increasing with 
recent data showing that worldwide over 1 in 10 infants are born prematurely (Blencowe H 
et al, 2012). It is the single most important cause of death within the first month of life (Liu L 
et al, 2012), with 2/3rds of UK neonatal deaths being attributable to prematurity (Wolfe I et al, 
2014).  
With advances in neonatal medicine, survival to discharge rates have improved dramatically 
from 40% in 1995 to 53% in 2006, in UK infants born at less than 26 weeks’ gestation (Costeloe 
K et al, 2012). However, the survivors of preterm birth have an increased risk of 
neurodevelopmental problems, with 19-21% of <26 weeks gestation infants having severe 
disability and 12-14% developing cerebral palsy (Moore T et al, 2012; Marlow N et al, 2005).  
As well as severe disability, preterm survivors have increased risk of cognitive, social, 
behavioural and later life psychiatric disorders. This is evidenced by literature which shows 
the following: 
1. Gestational age at birth has a significant dose-dependent relationship with special 
educational needs (SEN) (MacKay DF et al, 2010), with 57% of extreme preterm infants 
(gestational age < 25 weeks) having SEN and 13% requiring special school provision (Johnson 
S et al, 2009). 
2. Children who are born at less than 33 weeks have been shown to have reduced social 
competence including more peer relationship difficulties (Ritchie K et al, 2015).  
3. There is an increased risk of screening positive for autism or autistic spectrum disorder 
(ASD) in both extreme preterm (EPT <26 weeks gestation) (Johnson S et al, 2010a) and late 
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preterm (32 to 36 weeks’ gestation) infants (Guy A et al, 2015), with other studies quoting a 
65-fold increase in the prevalence of ASD compared to the general population in extremely 
preterm children (Johnson S et al, 2011).  
4. There is a gestational effect related to the most common behavioural deficit found in 
preterm infants, attention deficit (Sucksdorff M et al, 2015) with a prevalence of 9 to 11% in 
VPT (very preterm, <32 weeks gestation at birth) or VLBW (very low birthweight, <1500 
grams) which rises to 17 to 20% in EPT or ELBW (extremely low birthweight, <1000 grams) 
infants (Johnson S et al, 2011).  
5. And finally, individuals who were born preterm have an increased risk of developing 
psychiatric problems including anxiety (OR 3.5) and emotional disturbances (OR 4.6), 
(Johnson et al, 2010b) depression, psychosis and need for psychiatric hospitalisation (Nosarti 
C et al, 2012).  
   
1.1.2 Preterm Brain Injury 
 
There is a wide range of brain injury associated with preterm birth and altered 
neurodevelopmental outcome. Depending on their pathology, these changes may be 
diagnosed by neuroimaging techniques such as cranial ultrasound and MRI and may be seen 
on macroscopic and microscopic pathological examination of the brain. They include 
intraventricular haemorrhage (IVH), post haemorrhagic cystic degeneration and 
periventricular leukomalacia (PVL).  
1.1.2.1 Haemorrhagic Injury  
 
IVH is a common occurrence in preterm infants with 20-25% of VLBW infants developing some 
degree of IVH (McCrea HJ & Ment LR, 2008). It can be categorised as grade I – haemorrhage 
within the germinal matrix, grade II – intraventricular blood without ventricular dilatation, 
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grade III – intraventricular blood with ventricular dilatation and grade IV – parenchymal 
haemorrhage (Papile LA et al, 1978). IVH most often occurs within the 24 hour period after 
delivery, with most lesions reaching full extent by 7 days of age (McCrea HJ & Ment LR, 2008). 
The risk of developing IVH is altered by perinatal characteristics including gestational age, 
intrauterine growth restriction (IUGR), exposure to antenatal steroids, male gender, foetal 
distress and intrauterine infection (Heuchan A et al, 2002; Linder N et al, 2003 & Alexander 
JM et al, 1998). It is significantly associated with altered neurodevelopmental outcome, which 
worsens according to its severity, with an increased risk of cerebral palsy (OR 1.72 for grades 
I-II & 5.99 for grades III-IV) and with neurosensory impairment (OR 2.06 for grades I-II & 5.49 
for grades III-IV) found in infants born at less than 28 weeks’ gestation (Bolisetty S et al, 2014).  
IVH, in particular grade IV, may be associated with subsequent cystic degeneration of the 
white matter, which sees deletion of neurons, axons and glia within these necrotic lesions 
(Back SA & Miller SP, 2014). However, the pathophysiology of neurological damage as a 
consequence of IVH is not completely understood and may include iron activation of reactive 
oxygen species (Savman K et al, 2001) and alterations in neuronal precursor cell proliferation 













Figure 1.1 (A) Cranial ultrasound appearance of grade IV intraventricular haemorrhage and 
dilated ventricles and (B) left sided porencephalic cysts (anonymised images from Simpson 
Centre for Reproductive Health, Edinburgh UK) 
  
a.  b.  
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1.1.2.2 White Matter Injury 
 
Injury to the developing white matter in preterm infants and animal models presents as a 
spectrum where myelination failure is associated with diffuse white matter changes as well 
as macroscopic and microscopic focal cystic lesions. It generally occurs near the lateral 
ventricles and is therefore described as periventricular leukomalacia (PVL).  
Macroscopic cystic PVL involves the degeneration of all cell types including glia and axons 
however it is less common than other types, being diagnosed in <5% of MRI studies (Black SA 
& Miller SP, 2014).  
Microscopic cystic PVL, with lesions measuring <1mm in diameter are not visualised on MRI 
but may be diagnosed on neuropathological examination. Analysis of these lesions 
demonstrate their association with axonal degeneration and phagocytic macrophages (Black 
SA & Miller, 2014).  
The most prevalent form of white matter injury (WMI) diffuse PVL is characterised by loss of 
pre-myelinating oligodendrocytes with subsequent hypomyelination, astrogliosis and 




Figure 1.2 Cross sectional drawing of cerebrum depicting cystic (focal) PVL – white dots 
and non-cystic (diffuse) PVL as grey shading 
 
In the initial phase of white matter injury, there can be damage to 2 important cell types, the 
premyelinating oligodendrocyte (pre-OL) a glial cell precursor, and the neuronal axon.  
1.1.2.2a Axonal Degeneration 
Axonal injury and degeneration is a prominent feature where there is necrosis of the white 
matter, such as occurs in microscopic and macroscopic cystic PVL. It is thought that more 
severe hypoxic-ischaemic insult may select this pathologically distinct form of PVL. In contrast, 
milder hypoxic-ischaemic events may lead to diffuse PVL, which is less associated with axonal 
degeneration and more with dysregulation of the pre-OL (Black SA & Miller SP, 2014).  
1.1.2.2b Pre-Oligodendrocyte Dysregulation and Diffuse WMI 
The pathogenesis of diffuse white matter injury is multifactorial and involves upstream 
mechanisms including hypoxia/ischaemia and infection/inflammation as well as downstream 
mechanisms including microglia activation, excitotoxic processes and free radical attack 
(Khwaja O & Volpe JJ, 2008).  
Preterm infants are particularly susceptible to these mechanisms as a result of their clinical 
environment. Foetal distress around the time of birth, instability due to lung immaturity or 
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subsequent infections may lead to periods of hypoxia. These insults occur during a time 
period where the development of cerebral arteries is incomplete and may ultimately subject 
areas of the brain to severe ischaemia (Volpe JJ, 2001). Furthermore, infection and 
inflammatory processes are common events; chorioamnionitis affecting 40-70% of 
spontaneous onset preterm births (Yoon BH et al, 2001) and up to 25% of VLBW infants having 
at least one episode of late onset sepsis (Dong Y & Speer CP, 2015).   
 
During the preterm period, pre-OLs are the dominant oligodendrocyte cell lineage and this 
compounds the susceptibility of the preterm brain to white matter injury. Maturity-
dependent intrinsic properties of the pre-OL include an increased vulnerability to free radical 
attack (Khwaja O & Volpe JJ, 2008) and an increase in glutamate receptor expression (which 
mediates excitotoxic apoptosis) compared to more mature oligodendrocytes (Volpe JJ et al, 
2011). Additionally, microglia are particularly concentrated in white matter during the third 
trimester (Billiards SS et al, 2006) and their activation causes release of free radicals, harmful 
cytokines and augmentation of excitoxicity (Volpe JJ et al, 2011). These processes are 





Figure 1.3 Upstream and downstream mechanisms in the pathogenesis of periventricular 
leukomalacia  
(IVH = Intraventricular Haemorrhage, RNS = Reactive Nitrogen Species, ROS = Reactive 
Oxygen Species). Adapted from Volpe JJ et al, Int J Dev Neurosci 2011 & Fields RD, Nature 




























1.1.3 White Matter Structures and their Role in Disease 
 
The dysregulation of myelination associated with preterm WMI is not only manifest as PVL 
but also as abnormal growth and development of major white matter structures throughout 
the brain. The most widely studied white matter areas in preterm research being the major 
white matter fasciculi of the corpus callosum, the posterior limb of the internal capsule, the 
corticospinal tracts, the inferior longitudinal fasciculi, the cingulate and the white matter of 
the centrum semiovale. Before examining the role of these structures in preterm white injury, 
it is worth understanding their normal structure and function.  
 
1.1.3.1 The Corpus Callosum 
 
The corpus callosum is the largest white matter structure in the brain and the major 
transverse interhemispheric commissure (Thompson DK et al, 2011).  
It was first classified into seven geometric dissectible regions by Witelson (Witelson SF, Brain 
1989). The anterior section is known as the genu, the posterior as the splenium and the 
middle is referred to as the midbody (which is further divided in to anterior, middle and 
posterior midbody). Between the body and the splenium, there is a thinner segment known 
as the isthmus. The rostrum is anterior to the genu but curves backwards in posterior/inferior 
position. The structure of the corpus callosum is demonstrated in figure 1.4.  
The basic structure of the corpus callosum is thought to be complete by 18-20 weeks 
gestation, but continues to grow in size over the 3rd trimester (Malinger G and Zakut H, 1993). 
Although the number of fibres is fixed by full term (Lunders E et al, 2010), growth and 
maturation continues in to early adulthood (Giedd JN et al, 1996 & Tanaka-Arakawa MM et 
al, 2015). Studies have shown that maturational changes include increasing size of the whole 
structure but decreasing MRI signal intensity, which at a microstructural level may be related 
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to maturation of the axonal cytoskeleton increasing axonal size and myelination (Keshavan M 
et al, 2002).  
 
Figure 1.4 Regions of the Corpus Callosum 
 
 
Congenital abnormalities of the corpus callosum, including complete agenesis (AgCC) occur in 
1.8 in 10,000 live births (Glass HC et al, 2008). Although AgCC does not affect IQ scores or 
overall cognitive ability, it may cause problems with more sophisticated language skills and 
complex problem solving. Individuals with AgCC have been shown to have problems with 
understanding non-literal language and humour and may have poor conversational skills and 
difficulty verbalising emotions (Paul LK, 2011). These individuals also may have problems with 
attention; have difficulties with social self-awareness and display aggressive behaviour. This 
may lead to complications with social interactions and indeed there are similarities with 






1.1.3.2 The Corticospinal Tract   
 
The posterior limb of the internal capsule (PLIC) lies between the thalamus and the lentiform 
nucleus of the basal ganglia. It contains corticospinal (CST) tract fibres (Gan C & Maingard J, 
Radiopedia) as well as descending tract fibres from the parietal, temporal, and occipital lobes 
(Schmahmann JD et al, 2008).   
With regards to development, myelination of the CST occurs in the cranial direction, with 
posterior portions of the PLIC showing increased signal on T1 weighted images by 38-40 
weeks (Counsell SJ  et al, 2002) and continues until 14 months of age (Deoni  SCL et al, 2011).  
The absence of any myelination at term equivalent age (visualised using structural MRI, T1 
weighted sequence) has implications for neurodevelopment and is a risk for the development 
of hemiplegia (de Vries LS, 1999). Additionally, both macrostructural and microstructural 
asymmetry of the PLIC after periventricular haemorrhage, is significantly associated with 
unilateral spastic cerebral palsy, demonstrating that the CST has a major role in voluntary 
motor function (Roze E et al, 2015).  
 
1.1.3.3 The Centrum Semiovale  
 
The centrum semiovale (CSO) lies superiorly to the lateral ventricles and inferiorly to the 
cerebral cortex. It contains projection, commissural and association fibres (Gan C & Maingard 
J, Radiopedia).  
Projection fibres include striatal fibres that pass to the basal ganglia, pontine fibres which 
project to lower brain structures and the spinal cord and thalamic fibres. The commissural 
fibres are those which connect contralateral hemispheric regions, whereas association fibres 
travel between ipsilateral cortical areas and include local, neighbourhood and long 
association fibres (Schmahmann JD et al, 2008).  
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From disconnection observational studies, animal work and more recently advanced imaging 
techniques, the long association fibres can be characterised and functions elucidated. They 
include: The superior longitudinal fasciculus (SLF) and its three subcomponents, which are 
involved in proprioception, the initiation of motor activity, attention, visual awareness and 
articulating language. The arcuate fasciculus (AF) and the extreme capsule, both important 
for language and the middle longitudinal fasciculus, (MLF) which also deals with spatial 
organisation and memory. The uncinate fasciculus (UF) and inferior longitudinal fasciculus, 
(ILF) which appear to be significant in emotional visual processing. The fronto-occipital 
fasciculus (FOF) that is involved in visual spatial information and finally, the cingulum bundle 
(CB) that assists the emotional reaction to somatic sensation and nociception as well as having 
a role in attention, motivation, and memory (Schmahmann JD et al, 2008).  
Compared to the PLIC and corpus callosum, the centrum semiovale is later to mature and 
myelinate (Huppi PS et al, 1998). Measurements relating to microstructural maturation and 
myelination begin to increase in the MLF and UF at birth, the IFOF and ILF at 4 months of age 





1.2 Imaging Preterm Brain Injury  
 
Currently, standard practice for imaging of the preterm brain within the UK involves 
sequential cranial ultrasound. This imaging modality can reliably detect gross lesions such as 
IVH, cystic PVL and ventricular dilatation or hydrocephalus (Stewart AL et al, 1983 & de Vries 
LS et al, 2004), however the use of MRI at term equivalent age (TEA, 38 -42 weeks corrected 
gestation) allows closer inspection of diffuse white matter injury (Maalouf EF et al, 2001 & 
Inder TE et al, 2003).  
Conventional MRI allows qualification of brain maturation and injury at a macroscopic level, 
however advanced MRI techniques including diffusion tensor imaging (DTI) enables 
examination of brain tissue at the microstructural level and quantification of its development 
and organisation.   
1.2.1 Physics of Conventional MRI and Diffusion Tensor Imaging 
 
Before exploring the role of conventional and advanced MRI imaging in mapping preterm 
brain injury, it is worth having a basic understanding of the physics involved with these 
imaging processes.  
 
1.2.1.1 Conventional MRI 
 
The soft tissue of the body is composed mostly of water (H20), and each molecule contains 
two 1H which have a net magnetic moment capable of interacting with the MRI scanner. 
During MR imaging, a radiofrequency (RF) pulse is applied causing a change in the eigenstate 
of the 1H protons from spin up (low energy) to spin down (high energy). As they relax after 
excitation and return from spin down to spin up, they precess about the static magnetic field 
and induce a current in the receiver coil, which can be measured. The 1H protons in different 
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tissues relax at different rates and this causes the contrast which creates the MRI image we 
see (Hendee WR & Rietnour ER, 2002 and Graham DT et al, 2006).  
T1 Weighted MRI Sequence 
Within the brain, T1 sequences give good differentiation between white matter and grey 
matter. This sequence shows the differences in the ‘spin-lattice relaxation time’. Spin-lattice 
relaxation occurs as the protons release the energy they absorbed from a RF pulse. The 
‘lattice’ is the surrounding tissue, and this is heated up as the spins recover from a high energy 
state to a low energy state, which re-establishes thermal equilibrium. T1 relaxation time is 
different in every tissue and in general is longer where the magnetic field strength (measured 
in units of Tesla from 0.5 to 3) is higher (NessAvier M, 2008) 
T2 Weighted MRI Sequence  
In T2 sequences of the brain, cerebrospinal fluid (CSF) shows up lighter than the surrounding 
brain matter. T2 describes the signal decay, or the loss of coherence (MRI signal) between 
spins after the initial RF pulse. It is due to spin to spin as well as spin-lattice interactions but 
does not take in to account magnetic field inhomogeneities. Similarly to T1, it is different in 


















Figure 1.5 MRI imaging of the normal neonatal brain with a. T1w sequence and b. T2w 











1.2.1.2 Diffusion Tensor Imaging 
 
Diffusion tensor imaging was first introduced in to clinical practice in the 1990s. It is based on 
the theory of ‘Brownian motion’ which describes the random motion of molecules due to 
heat (Mukherjee P et al, 2008).  The movement of water molecules by Brownian motion can 
be described graphically by a 3D ellipsoid. Diffusion of water molecules is restricted by the 
tissue microstructure, reducing the apparent rate of diffusion; the axes of the ellipsoid 
indicate the apparent diffusion coefficient in each direction. The orientations of the axes of 
the ellipsoid are dependent on eigenvectors and their length on eigenvalues (λ1, λ2 and λ3) 
which represent diffusion along the tensor axes (Huppi PS & Dubois JS, 2006). Within 
biological matter, water molecules will diffuse differently according to tissue type, its 
underlying architecture and microstructural barriers (Soares JM et al, 2013). For example, in 
the brain CSF water diffuses equally in all directions (termed isotropic motion) and hence the 
ellipsoid is spherical in shape. In white matter, the diffusion of water has a directional quality 
(termed anisotropic). White matter is organised into bundles and the neuronal fibres are 
surrounded by myelin which insulates by decreasing the membrane permeability. As such, 
diffusion of water is faster parallel to the fibres than perpendicular. The more organised the 
white matter is, the higher the anisotropy will be. In this situation, the diffusion tensor is cigar 








Figure 1.6 The diffusion tensor ellipsoid  
a. Eigenvectors determining direction and eigenvalues length of each axis. b. In CSF the 













To measure this diffusion of water using MRI, the Stejskal-Tanner imaging sequence is used. 
This applies two equally strong but opposite gradient pulses around a 180 degree refocusing 
pulse. The first pulse causes a phase shift for all spins; the second cancels this out if there has 
been no net movement of water. However, if there is movement due to Brownian motion the 
spins are not completely refocused and there is signal loss which can be measured (Westin 
CF et al, 2002).  
Within a particular voxel, quantitative measures of diffusion can be calculated – the fractional 
anisotropy and mean diffusivity. Mean diffusivity (ADC, Dav, MD) is the mean of the 3 
eigenvalues and describes the directionally averaged diffusivity of water with higher rates 
reflecting more water diffusion in a particular tissue (MD in free water at body temperature 
is approximately 3.0 x 10-3 mm2/s) and lower signal intensity in the diffusion weighted image 
(Mukherjee P et al, 2008, Huppi PS & Dubois JS, 2006). Fractional anisotropy (FA), describes 
the overall directionality of the water diffusion and an indication of the ellipsoid shape 
(Alexander AL et al, 2007). FA is 0 in tissues where the diffusion is completely isotropic and 
moves towards 1 where there is total anisotropy (Huppi PS & Dubois JS, 2006).  
There are several methods for analysing the quantitative measures of diffusion and these 
include region-of-interest based and tract-based approaches. Region-of-interest is the more 
traditional DTI approach which may be the only option in some clinical software packages. It 
performs calculations on the original MRI slice, this eliminating post processing errors 
(Hakulinen U et al, 2012). However, it has been shown to have low repeatability (Bisdas S et 
al, 2008) and high variability (Bonekamp D et al, 2007). Tract-based approaches average FA 
and MD for the entire white matter fibre bundle however data can be affected by image 




MD and FA are not fixed in a particular tissue throughout development and within the brain, 
alterations in their values are felt to reflect changes in water content, myelination, growth 
and organisation of neuronal tissue. Generally, MD values fall with increasing age and this is 
related to the water content of the brain lessening as an individual matures. In addition, 
structures that restrict water movement - such as axons - become more densely packed and 
organised. FA values increase with age and this is observed in line with myelination of a 
particular white matter structure. It is also seen pre-myelination where it is explained by 
histological changes including axonal membrane permeability, the presence of microtubule-
associated proteins, increases in axonal calibre and increases in oligodendrocytes (Huppi PS 






1.2.2 Imaging the Developing Brain in relation to Neurodevelopmental Outcome  
 
1.2.2.1 Conventional MRI 
 
MRI of preterm infants at TEA allows closer inspection of white matter changes such as diffuse 
WMI and allows examination of the posterior limb of internal capsule and cerebellum which 
are difficult to visualise on cranial ultrasound (Maalouf EF et al, 2001 & Inder TE et al, 2003).  
In a study of 167 VPT infants, Woodward et al categorised the preterm MRI brain phenotype 
into categories of white matter abnormalities and showed that moderate to severe changes 
were highly predictive of cognitive delay (OR 3.6), motor delay (OR 10.3), cerebral palsy (OR 
9.6) and neurosensory impairment (OR 4.2) (Woodward LJ et al, 2006).  
However, the specificity of conventional MRI to predict survival without cerebral palsy is 
similar to cranial ultrasound (85 to 96%) where no major abnormalities are present (Valkama 
AM et al, 2000; Mirmiran M et al, 2004; Woodward LJ et al, 2006; de Vries LS et al, 2011) and 
although it is more sensitive (60 to 92%) than cranial ultrasound to predict survival with CP, 
reported confidence intervals are wide (Valkama AM et al, 2000; Mirmiran M et al, 2004; 
Woodward LJ et al, 2006; Skiold B et al, 2012).  
Therefore, current British Association of Perinatal Medicine guidance is to obtain a structural 
MRI for preterm infants at TEA only if there is evidence of parenchymal injury on cranial 









Figure 1.7 Classification of white matter abnormalities on T2 weighted MRI.  
a. Normal MRI appearance b. Mild WM abnormalities c. Moderate WM abnormalities and d. 
Severe WM abnormalities characterised by ‘increasing ventricular size, decreasing white-
matter volume and increasing intensity of white-matter signal’ (Reproduced with permission 
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1.2.2.2 Diffusion Tensor Imaging 
 
It is known that the quantitative measures of FA and MD are dynamic with increasing age and 
gestation (Huppi PS et al, 1998, Huppi PS & Dubois JS, 2006).  
However, it has been shown that the underlying processes of development (myelination and 
white matter structural maturation) can be disrupted in preterm white matter injury. The 
effects of these injurious processes can be seen on structural MRI and can also be quantified 
using DTI. A study of serial MRI scans over 2-6 weeks after birth and again at term corrected 
age, showed that MD does not decrease and FA does not increase with increasing age in 
preterm infants with moderate white matter disease compared to those without (Miller SP et 
al, 2002). In addition, the appearance of white matter injury visible as DEHSI (diffuse excessive 
high intensity) on structural MRI is associated both with increases in MD compared to preterm 
infants without (Counsell S et al, 2006) and a reduction in relative anisotropy at the site of 
primary injury and within other distant white matter structures such as the PLIC (Huppi PS et 
al, 2001).  
With regards to neurodevelopment, there is a large body of evidence linking alterations in DTI 
measurements and outcome in preterm infants. Table 1.1 summarises the findings from 
groups which have investigated the relationship between quantitative DTI measurements in 
major white matter structures (as outlined in 1.1.3) and neurodevelopmental outcome in the 
at risk neonatal population. These studies show that in specific white matter regions, a 
reduction in FA and increase in MD is associated with poorer outcomes in areas that include 
motor function, cognition and neurosensory development.  
Therefore, we can describe DTI measurements as quantitative biomarkers of preterm brain 
injury which are predictive of neurodevelopmental outcome after preterm birth.
44 
 
Table 1.1 The effect of prematurity on neurodevelopmental outcome as assessed by DTI – a summary of evidence in the literature  
 
Note: CC = corpus callosum, CP = cerebral palsy, DQ = developmental quotient, TEA = term equivalent age, ROI = Region of Interest Analysis, 
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1.3 Early Life Stress and the Role of Epigenetic Modification  
 
1.3.1 The Developmental Origins of Health and Disease  
 
The environment that the preterm infant experiences (Figure 1.9) is both physically stressful, 
with exposure to bright lights, high noise levels and noxious stimuli (Als H et al, 2004),  and 
physiologically stressful due to hemodynamic instability and variable oxygen levels, 
temperature change, altered nutrition and susceptibility to infection. It is well documented 
that early life adversity is related to poor health outcomes. This was first described by Barker 
et al, who demonstrated that low birth weight was related to cardiovascular disease in later 
life (Barker DJ, 2007). Following on from this, several studies revealed that malnutrition in 
early life is linked to risk of later life health problems. For example, offspring from survivors 
of the Dutch Famine have alterations in their lipid profiles (Lumey LH et al, 2009) and 
differential rates of obesity (Ravelli GP et al, 1976) and paediatric survivors and offspring of 
survivors of the Chinese Famine have alterations in growth and rates of hypertension (Huang 
C et al, 2010). Additionally, within both these populations, early life adversity confers an 
increased risk of neuropsychiatric disease with increased rates of schizophrenia (Susser E et 
al 1992, St Clair D et al, 2005).  
The molecular basis for the so called ‘developmental origins of health and disease’ include 
glucocorticoid excess and alterations to the hypothalamic–pituitary–adrenal axis (HPA), 
which in human and animal models of early life adversity are shown to be associated with 
hypertension, altered glycaemic control and behavioural changes (Drake AJ et al, 2007). These 
effects are transmissible throughout subsequent generations giving rise to the theory that 














Figure 1.8 The neonatal intensive care environment 












1.3.2 Epigenetic Processes and DNA Methylation  
 
The term epigenetics refers to a group of cellular mechanisms which alter gene expression, 
either transiently or permanently, without alteration to the underlying genome and in 
response to exogenous signals. They include DNA methylation, histone modifications (with 
acetylation, methylation, phosphorylation, ubiquitinyation and sumoylation) and non-coding 
RNAs (Nugent BM et al, 2015).  
DNA methylation (DNAm) is the most commonly studied epigenetic mechanism and involves 
the addition of a methyl group to cytosine, most often at CpG dinucleotides, where cytosine 
is joined to guanine by a phosphate bond, to form 5-methylcytosine (5mC).  Interestingly, the 
majority of CpG islands (areas of the genome which are rich in CpG regions) are usually not 
methylated, and the promoters of ‘housekeeping genes’ are often embedded in these areas. 
When CpG islands are methylated, this leads to transcriptional silencing or turning off of the 
gene by inhibition of transcription factor binding (Moore LD et al, 2013). DNA methylation is 
dynamic, particularly during early development and therefore fundamental to such processes 
as embryogenesis, gene imprinting and X chromosome inactivation (Shi L et al, 2009). It is 
regulated by a group of highly conserved proteins, DNA methyl transferases (DNMTs) with 
DNMT3s establishing de novo methylation in early development and DNMT1 preserving 









1.3.3 DNA Methylation  
 
1.3.3.1 In Relation to Stressful Life Events 
 
Both animal and human studies have shown that early life experience and stress can cause 
alterations to DNA methylation.  
In mice, the early social environment is determined by differences in maternal care and is 
associated with long term behavioural outcomes and tissue specific differences in DNA 
methylation (DNAm) at the glucocorticoid receptor (GR) gene promoter within the 
hippocampus (Weaver IC et al, 2004). Similarly, prenatal stress during the first week of 
gestation causes alterations in DNAm of the corticotrophin-releasing factor (CRF) and GR 
genes, with associated changes in expression and offspring behaviour (Mueller BR et al, 2008). 
Additionally, in rat pups that are exposed to caregivers with abusive behaviour, there is 
alteration in DNAm at the BDNF (brain derived neurotrophic factor) gene expression in the 
adult prefrontal cortex (Roth TL et al, 2009).  
In human studies, epigenetic analysis of individuals prenatally exposed to famine in the Dutch 
cohort has revealed alterations in DNA methylation at the IGF2 gene (Heijmans BT et al, 2008) 
and other loci implicated in growth and metabolism (Tobi EW et al, 2009). Examination of 
post mortem hippocampal tissue from suicide victims who experienced childhood abuse 
showed significant differences in DNAm across a range of neuronal gene promoters (Labonte 
B et al, 2012) and epigenome wide interrogation of blood samples from children raised in 
institutions compared to those raised by their biological parents revealed global increases in 
DNAm (Naumova OY et al, 2012). Several studies have also demonstrated differences in 
DNAm at the GR as well as altered stress reactivity in adults with a history of childhood abuse 
or adversity (McGowan PO et al, 2009, Tyrka AR et al, 2012).  
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1.3.3.2 Role in Normal Brain Development and Neural Function 
 
DNA methylation is critical for normal embryogenesis, demonstrated by DNMT1 KO models 
which results in a recessive lethal phenotype (Li E et al, 1992). In addition, there is a large 
body of evidence that DNAm is essential for neuronal development and neural function.  
Mammalian brains show widespread expression of the key enzymes which mediate DNAm, 
DNMT1, DNMT3a and DNMT3b, which along with levels of 5mC vary by brain region and stage 
of postnatal development (Simmons RK et al, 2013). Differential patterns of DNA methylation 
are also demonstrated by MethylC-Seq in various brain regions of both mice and human 
samples and also vary according to cell type and stage of development, with neuronal cells 
and adult brains showing more DNAm at non-CpG sites compared to oligodendrocytes, 
embryonic stem cells and fetal brains (Lister R et al, 2013).  
Selective knockout (KO) of DNMT1 in mouse embryonic CNS precursor cells causes 
hypomethylation of neuronal cells, with postnatal cell death and respiratory failure from 
abnormal neural control in the mutant offspring (Fan G et al, 2001). Using this KO mechanism 
crossed with a mutation which allows the mice to survive in to adulthood, Hutnick et al 
produced a generation of mice with ~90% hypomethylation in the dorsal forebrain. These 
animals showed striking cortical and hippocampal degeneration characterised by neuronal 
cell loss and severe deficits in learning and memory (Hutnick LK et al, 2009).   
At the synaptic level, in vitro studies have shown that addition of DNMT inhibitors at the 
Schaeffer collateral-CA1 pathway reduces the magnitude of long term potentiation (LTP), 
which serves as a cellular correlate of learning (Levenson JM et al, 2006). In accordance with 
this, mutant mice with selective forebrain neuron DNMT1 and DNMT3a knockouts show 
similar impairment of LTP in hippocampal CA1 regions along with deficits of learning and 
memory demonstrated in behavioural testing (Feng J et al, 2010).  
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In reference to the importance of oligodendrocyte (OL) integrity in preterm white matter 
injury, DNA methylation has been shown to be significantly involved in OL development.  
Overall levels of 5-mC increase in OLIG2+ cells during stages of embryonic and postnatal 
mouse development and DNMT1 levels increase during in vitro differentiation of OLs.  
Furthermore, ablation of DNMT1 causes severe hypomyelination of the brain stem and spinal 
cord with subsequent ataxia and reduced survival in the mutant mouse population (Moyon S 
et al, 2016).  
In addition to the involvement of DNMTs, a group of proteins known as MBDs or methyl 
binding domain proteins have been implicated in neurological processes and disease. These 
proteins bind to methylated regions of DNA and recruit histone deacetylase (HDAC) repressor 
complexes which inhibit transcription (Roloff TC et al, 2003). MBD1 KO mice display impaired 
spatial learning, reduced adult neurogenesis and a reduction in LTP in the hippocampus (Zhao 
X et al, 2003). This mutation is also associated with behavioural traits in mice similar to the 
pattern seen in autism, with anxiety, reduced social interaction and learning deficits (Allan 
AM et al, 2008).  
 
1.3.3.3 Role in Neurological Disease 
 
Of all the MBD proteins, MeCP2 is the most studied due to its involvement in Rett syndrome 
(RTT). RTT is characterised by neurological regression, mental retardation, autistic features 
and occurs exclusively in females, (Graff J & Mansuy IM, 2009) with imaging studies showing 
a reduction in both grey and white matter volumes (Naidu S et al, 2001). The majority of cases 
off RTT are caused by a mutation in the MeCP2 gene (Amir RE et al, 1999) and in mouse 
models this is associated with a reduction in levels of brain derived neurotropic factor, (BDNF) 
which is essential for neuronal survival (Chang Q et al, 2006).  
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With regards to other identifiable pathological neurological phenotypes, alterations in DNAm 
- both at specific gene loci and across the entire genome - have been implicated in the 
development of psychiatric disorders such as schizophrenia (Abdolmaleky HM et al, 2006, 
Huang HS et al, 2007, Iwamoto K et al, 2005), bipolar disorder (Fries GR et al, 2016) and 
depression (Khulan B et al, 2014, Tyrka AR et al, 2016, Poulter MO et al, 2008) and also 
behavioural disorders including autism (Loke YJ et al, 2015) and attention deficit (Walton E et 
al, 2016). As discussed earlier, infants that are born preterm have an increased risk of 
developing these behavioural and psychiatric problems.  
 
1.3.3.4 In Relation to the Perinatal Environment 
 
The perinatal risk factors for preterm birth include modifiable environmental conditions such 
as maternal diet and smoking as well as pathologies such as preeclampsia and 
chorioamnionitis, which may be treated but not necessarily prevented.  Several studies have 
shown an association between these events and alterations in DNA methylation and 
therefore we may expect to see a significant difference in DNAm in preterm infants compared 
to those delivered at term.  
The effect of malnutrition in pregnancy from famine cohort studies has already been 
discussed. However, further nutritional studies demonstrate that even an unbalanced 
maternal diet is associated with alterations in long term health outcomes in adult offspring 
including hypertension and raised cortisol levels and that these changes are associated with 
variation in DNA methylation at the glucocorticoid receptor in humans (Drake AJ et al, 2012). 
In addition, folic acid (an important methyl group donor) restriction antenatally is associated 
with global DNA hypomethylation in the intestine of mice offspring (McKay JA et al, 2011). In 
terms of postnatal nutrition, preterm infants have immature gastrointestinal tracts compared 
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to term infants and therefore their feeding must be carefully managed with the gradual 
introduction of enteral milk and support with TPN (total parenteral nutrition). The feeding 
and nutritional support of preterm infants is fraught with risk of intravenous catheter related 
infection and necrotizing enterocolitis, an inflammatory condition of the gut. Both are 
associated with poor neurodevelopmental outcome (Abott J et al, 2017) and therefore 
preterm cohorts have a very different experience with nutrition compared to term babies.  
Maternal smoking during pregnancy is known to be associated with preterm birth and 
significantly reduced birth weight. DNA methylation and subsequent increased expression at 
CYP1A1, a gene encoding for an enzyme that catabolises carcinogenic polycyclic aromatic 
hydrocarbons to harmful DNA adducts, is reduced in the placentas of smokers compared to 
non-smokers (Suter M et al, 2010). Additionally, maternal smoking is associated with 
alterations in DNAm at the imprinted gene IGF2 and glucocorticoid receptor (GR/NR3C1) in 
fetal liver (Drake et al, 2015).  
In the UK, socioeconomic class is strongly associated with low-quality diet (Roberts K et al, 
2013), increased rates of maternal smoking during and after pregnancy (Dhalwani N et al, 
2013) and increased rates of premature birth (Glinianaia SV et al, 2013) and therefore preterm 
infants may have additional risks compared to term infants.  
Pathological states which may precipitate preterm birth include pregnancy induced 
hypertension and its progression to pre-eclampsia, infection such as chorioamnionitis and 
metabolic states including gestational diabetes. Pre-eclampsia, which involves placental 
insufficiency and high maternal blood pressure may also lead to intrauterine growth 
restriction and iatrogenic preterm delivery. Increased DNAm in specific gene loci including 
VEGF, FLT-1 and KDR (factors which are critical for angiogenesis) was found in the placentas 
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of women with preeclampsia compared to those without, with more significant changes 
present in cases of preeclampsia and preterm delivery (Sundrani DP et al, 2013).  
Gestational Diabetes (GD) occurs in 3.5% of UK pregnancies and is characterised by impaired 
maternal glucose tolerance in the second trimester (Finer S et al, 2015).  Offspring have higher 
rates of obesity than controls (Fetita LS et al, 2006). A genome wide analysis has shown GD is 
associated with differential DNA methylation not only in maternal placentas but also in cord 
blood samples compared to controls (Finer S et al, 2015).  
Chorioamnionitis is characterised by inflammation of the foetal membranes on histological 
examination of the placenta. After preterm birth it is associated with increases in DNAm at 
the imprinted gene, PLAGL1. This gene is involved in tumour development and growth via 
IGF2 signalling, providing further evidence that early life environmental factors can affect 
later life disease susceptibility (Liu Y et al, 2013).  
With regards to the effect of preterm birth as an independent variable, epigenome wide 
association studies (EWAS) have shown an association between gestational age and DNA 
methylation at specific gene loci with roles in haematopoiesis and the developmental of the 
brain and skeletal muscle (Lee H et al, 2012).  
There are several recent candidate genome studies which have assessed DNAm in relation to 
neurobehavioural outcomes and cognitive development in term infants (Bromer C et al, 2013, 
Paquette AG et al, 2013 & Paquette AG et al 2014) yet there have been few studies examining 
the association of DNA methylation with preterm birth and long term outcome. In 2013, 
Cruickshank et al reported on levels of DNAm preterm infants (less than 31 weeks gestation) 
compared to term controls at birth and at 18 years of age. They showed differential 
methylation in 1,555 promoters (DMPs) at birth; for genes involved in GTPase signalling, 
transcription, cell growth and proliferation, neurological and haematological development. 
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These observed differences had resolved in the majority of DMPs by 18 years of age, but 10 
CpG regions showed persistent changes (Cruickshank MN et al, 2013), thus providing evidence 
that preterm birth has a long term epigenetic legacy.  
Therefore, in terms of early life experience, preterm infants may encounter a stressful 
intrauterine environment which is infected, has inadequate blood flow or altered metabolism 
in the case of gestational diabetes. They may have a mother who smokes or has a poor diet 
and post-natally they have a vastly different nutritional experience compared to term infants. 
These factors in combination with the multitude of difficult clinical scenarios preterm infants 
face compared to term infants such as sepsis, fluctuations in oxygen and altered temperature 
to name a few, all contribute to the risk of abnormal neurodevelopment, a risk which may 
leave its fingerprints by alterations in DNAm.  
1.3.3.5 Variation Across Tissue Types 
 
Patterns of DNA methylation are tissue specific, particularly during development (Song F et 
al, 2009) and as such serve as an important mechanism for the translation of the same genetic 
material to determine different cell type and function (Bird A, 2002). Therefore, ideally 
epigenetic studies should be conducted in the tissue of interest. With regards to 
neuroepigenetics, tissue specific studies are limited to translational animal models or post 
mortem cases. Nevertheless, it is important to consider that in post mortem studies the cause 
of death, mode of death and interval between death and collection of post-mortem material 
may affect DNA methylation (Rhein M et al, 2015).  
If we wish to study DNAm in live human subjects, the selection of an accessible surrogate 
tissue is required. Recently, several studies have shown consistency between patterns of 
DNAm in the brain and peripheral tissue. For example, early life stress manifest by differential 
55 
 
rearing of Rhesus Macaques is associated with changes in DNAm in both the prefrontal cortex 
as well as peripheral T cells (Provencal N et al, 2012). Additionally, methylation of COMT in 
peripheral blood mononuclear cells (PBMCs) is associated with lifetime stress in humans, and 
that methylation patterns of COMT in the prefrontal cortex and PBMCs of rats are comparable 
(Ursini J et al, 2011). Other studies have also demonstrated similarities in DNA methylation at 
specific candidate genes between post mortem brain tissue of people with schizophrenia and 
saliva (Nohesara S et al, 2011 and Ghadirivasfi M et al, 2011).  
In paediatric studies, the least invasive sampling of DNA material is preferable, and studies 
have shown that saliva samples even in small volumes produce good quality and quantity of 
DNA for genomic work (Nemoda Z et al, 2011). Genomic wide studies also show a positive 
correlation between patterns of DNA methylation in brain tissue, saliva and blood (Smith AK 
et al, 2015 and Wockner LF et al, 2014) with saliva showing better correspondence. This 
finding is further emphasised by comparison of DNA derived from blood and saliva with other 
tissues, revealing that buccal cells from saliva show significantly greater overlap with 
hypomethylated regions in other tissues (Lowe R et al, 2013). Therefore, the effect of DNAm 









1.4 Hypotheses and Aims  
I hypothesised that preterm birth would have a significant effect on DTI parameters in white 
matter tracts at term equivalent age.  
I hypothesised that there would be an associated effect from clinical risk and resilience factors 
on DTI parameters in white matter tracts of preterm infants at term equivalent age.  
As DTI parameters can be assessed by region of interest and tract averaged techniques, I 
hypothesised that there would be good repeatability of ROI analysis but limited agreement 
between measurements of FA and MD generated by these methods.  
I hypothesised that there would be a significant difference in DNA methylation between 
preterm infants sampled at term equivalent age and term control subjects and significant 
alteration in DNAm at gene loci which are associated with neurological function and/or 
neurological disease.  
Finally, I also hypothesised that variance in DNAm is associated with dMRI parameters in 





Therefore, my aims were: 
 
1. To examine the relationship between preterm birth and white matter integrity 
2. To investigate the effect of neuroprotective treatments and deleterious clinical states 
on white matter integrity in preterm infants  
3. To assess the best method of quantifying white matter integrity in a neonatal 
population by determining agreement between ROI and tract-based analysis  
4. To investigate the effect of preterm birth on DNA methylation  
5. To determine the clinical and imaging factors that contribute to the variance in DNA 




Chapter 2: Materials and Methods 
2.1 Patient Recruitment  
2.1.1 Ethics  
This thesis included patients from 2 separate ethics applications.  
1. Ethical approval was granted from the National Research Ethics Service South East 
Scotland Ethics committee 2, reference number (REC) 11/SS/0061, (R&D) 
2011/R/NE/04, principle investigator Professor James P Boardman.  
2. Ethical approval was granted from the National Research Ethics Service South East 
Scotland Ethics committee 2, reference number (REC) 13/SS/0143, (R&D) 117024, 
principle investigator Professor James P Boardman.  
The study was conducted in accordance with the recommendations for physicians involved in 
research on human subjects adopted by the 18th World Medical Assembly, Helsinki 1964 and 
later revisions.  
2.1.2 Inclusion and Exclusion Criteria  
INCLUSION CRITERIA 
Group 1. Preterm infants born weighing less than 1500 grams at birth and/or being less than 
32 weeks’ gestation and cared for at The Simpson Centre for Reproductive Health.  
Group 2. Term infants born at more than 37 weeks’ gestation and weighing more than 1500 
grams at The Simpson Centre for Reproductive Health. 
All infants had to be fit for MR scanning at the CRIC (clinical research imaging centre) at term 





EXCLUSION CRITERIA  
 Any infant who did not pass the standard MR safety checklist including infants with an 
implanted medical device. 
 Infants with congenital anomalies and chromosomal abnormalities 
 Infants with overt parenchymal lesions including haemorrhagic parenchymal 
infarction (HPI) and cystic PVL visualised on cranial ultrasound. 
 
WITHDRAWAL CRITERIA  
If the person with parental responsibility for a participant withdrew consent he/she was able 
to do so without giving reason and with the assurance that the clinical care was not 
compromised.  
2.1.3 Recruitment Pathway  
Preterm participants from the Neonatal Intensive Care Unit and term participants from the 
postnatal wards at the Royal Infirmary of Edinburgh that met the inclusion and exclusion 
criteria were identified by a trained research fellow (Dr Sarah Sparrow, Dr Chinthika Piyasena, 
Dr Rozi Pataky and Dr E Telford).  
A person with parental responsibility was then invited to enrol their child into the study. They 
were given verbal and written information about the study. They were given as much time as 
they desired to consider participation.  
If the person with parental responsibility agreed to participation, a date and time for 
attendance at the Clinical Research Imaging Centre (CRIC) was given. 
Infants of multiple gestation i.e. twins were consented as individual subjects. Therefore, the 
person with parental responsibility could consent, if they so wished, to include 1 twin but not 
60 
 
the other in to the study. It was also possible, that 1 or more infant(s) from a multiple 
gestation did not meet inclusion criteria/met exclusion criteria due to illness or mortality.   
2.1.4 Consent  
Informed written consent was obtained from a person with parental responsibility of the 
participating child. This included the option of withdrawal from the study at any stage of 
investigation.  
2.1.5 Confidentiality  
As part of the direct healthcare team the Principle Investigator and I had direct access to 
medical records. I adhered to the NHS code of practice for confidentiality and no unnecessary 
members of the research team had access to identifiable clinical information. 
2.2 MRI Data Collection and Analysis  
2.2.1 Pre-MRI Procedure  
The infant was brought directly to the CRIC from home after the infant was discharged from 
the unit or postnatal ward. If the infant was still resident on the NICU or postnatal ward and 
deemed fit enough to visit the CRIC, he/she and the parents were taken over by the paediatric 
research nurse and the paediatric research fellow (Dr Sarah Sparrow, Dr Chinthika Piyasena, 
Dr Rozi Pataky and Dr E Telford). 
At the reception area, a radiographer went through standard MR safety procedures.  
The families were taken to the treatment room adjacent to the MR scanner, where the infants 
were examined, weight, OFC (occipital-frontal circumference of head) and temperature 
measured and findings documented. If the infant had clothing containing metal this was 
removed and replaced with metal free clothing.  




The infants were then given a feed (if considered timely) and wrapped in a blanket. Ear 
protection (Ear plugs and ‘MiniMuffs’) was applied to reduce disturbance from the noise of 
the MR scanner.  
2.2.2 MR Imaging  
Once asleep, the infant was taken to the adjoining MRI scan room. The parents were asked 
to wait in the adjoining waiting room. The infant was placed on the movable scan table on a 
moulding suction mattress and monitoring leads connected to the monitor. The scan duration 
was between 30 and 60 minutes depending on how still the infant remained.  
A Siemens Magnetom Verio 3 T MRI clinical scanner and 12-channel phased-array head coil 
were used to acquire: T1-weighted MPRAGE volume (1 mm3 resolution, TR = 1650 ms, TE = 
2.43 ms, inversion time = 160 ms, flip angle = 9°, acquisition plane = sagittal, FOV = 256 mm, 
acquired matrix = 256 × 256, acquisition time = 7 min 49 sec and acceleration factor = 2), T2-
weighted STIR (Short T1 inversion recovery, 0.9 mm3 resolution), to allow fat suppression and 
allow better structural visualisation, T2-weighted FLAIR (Fluid-attenuated inversion recovery, 
1 mm3 resolution), to allow for CSF suppression and better identification of periventricular 
lesions, and diffusion MRI (11 T2- and 64 diffusion encoding direction (b=750 s mm−2) single-
shot spin-echo planar imaging volumes with 2 mm isotropic voxels using a prototype 
sequence, TR = 7300 ms, TE = 106 ms, FOV = 256 mm, acquired matrix = 128 × 128, 50 
contiguous interleaved slices with 2 mm thickness, acquisition time = 9 min 29 s). To reduce 
eddy current induced artefacts and shimming errors to a minimum in the dMRI protocol, an 
optimized bipolar gradient pulse scheme was employed with a manually selected shim box 
covering a region extending from the top of the head to several centimetres below the chin. 
The infant's vital signs (saturation and heart rate) were monitored throughout with a 
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paediatric fellow and nurse in attendance. The MR examination was stopped if there were 
any signs of instability or distress. 
The MRI protocol was optimised for neonatal subjects by Dr Mark Bastin, Dr Scott Semple and 
Dr Devasuda Anblagan before my involvement in this project began.  
2.2.3 MRI Data Storage  
Following acquisition MR images were immediately anonymised and stored offsite on a 
computer network in the King’s Buildings, University of Edinburgh. The whole file system was 
backed up and the processed data were also backed up at regular intervals.  
2.2.4 MRI Processing  
This stage was conducted by Dr Devasuda Anblagan. After conversion from DICOM to NIfTI-1 
format, diffusion MRI data were pre-processed using FSL tools (FMRIB, Oxford, UK; 
http://www.fmrib.ox.ac.uk). This included brain extraction and removal of bulk infant motion 
and eddy current induced artefacts by registering subsequent diffusion-weighted volumes to 
the first T2-weighted EPI volume for each subject. Using DTIFIT, MD and FA volumes were 
generated for every subject. Underlying connectivity data was provided by FSL’s 
BedpostX/ProbTrackX algorithm run with its default parameters: 2-fiber model per voxel, 
5000 probabilistic streamlines for each tract with a fixed separation distance of 0.5 mm 
between successive points (Behrens TE et al 2003 & Behrens TE et al 2007).   
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2.2.5 DTI Data Analysis 
2.2.5.1 Region-Of-Interest Analysis  
DTI images were visualized in the axial plane in 2mm slices using FSL viewer. Images were 
interpolated post-acquisition. The best slice for the corresponding ROI (genu corpus callosum, 
left or right PLIC, left or right anterior, middle and posterior centrum semiovale or cerebral 
white matter) was identified anatomically as described below, with the use of 
www.mrineonatalbrain.com as a reference guide.  ROI placement is shown in figure 2.1.  
Genu of Corpus Callosum: Axial view (figure 2.1a) shows anterior and posterior horns of both 
lateral ventricles, with genu being found between the superior margins of the ventricles, 
below the cerebral cortex in the midline.  
Posterior Limb of Internal Capsule: Axial view (figure 2.1b) shows basal ganglia with PLIC 
visible as 2 diagonal bands of increased signal intensity. Voxels were placed inferior-lateral 
along this region with an attempt to standardise position between subjects. Voxel placement 
was as follows:  
Right PLIC = 1 Left PLIC = 2  
Centrum Semiovale (CSO): Axial view (figure 2.1c) shows cerebral cortex with cerebral white 
matter visible as confluent higher signal intensity without capture of superior margins of 
lateral ventricles. Voxel placement was as follows: Anterior = 1 and 4, Central = 2 and 5, 
Posterior = 3 and 6 
Care was taken to avoid capture of cortical fold when placing voxels.  
Diffusion values (MD and FA) were manually extracted from a 1mm3 ROI placed at the centre 
of each ROI and calculated using an in house MATLAB algorithm, designed with the help of 
Dr. Mark Bastin.  
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Figure 2.1 FA maps with ROI placement in the a. genu of corpus callosum, b. left and right 






2.2.5.2 Tractography  
Probabilistic neighbourhood tractography was performed by Dr. Devasuda Anblagan to 
provide whole tract averaged values of MD and FA for the Genu of the Corpus Callosum and 
left and right Corticospinal Tracts. The method used was first described by Clayden et al 
(Clayden JD et al, 2006 & Clayden JD et al, 2007) and developed for use with neonatal dMRI 
data by Anblagan et al (Anblagan D et al, 2015). 
Candidate tracts were generated by seeding within a 7 x 7 x 7 neighbourhood of native space 
voxels, centred around a standard space seed point, defined using age specific T-2 weighted 
neonatal template, (Kuklisova-Murgasova M et al, 2011), located at the centre of a particular 
white matter structure-of-interest, and then transferred to the native space of each control. 
An experienced observer (Dr D Anblagan) selected the tracts from each control which best 
matched the anatomical shape of the white matter structure-of-interest. These ‘best-
matching’ tracts were used to fit tract shape models to the tractography using maximum 
likelihood (Clayden JD et al, 2007), therefore capturing shape and length variation amongst 
the control’s tracts. After creation of the reference tracts and shape models, PNT was re-run 
over a neighbourhood of 3 x 3 x 3 voxels, centred on the reference tract and transferred to 
the native space for all subjects; the seed point that produced the ‘best matching’ tract to the 
a. b. c. 
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reference tract was then determined. The computational analysis was implemented in 
TractoR (http://www.tractor-mri.org.uk). The tractography masks of the best match tracts 
were applied to each subjects’ MD and FA maps, allowing tract-averaged values to be 
determined for each of the tract of interest.  
2.3 DNA Collection 
2.3.1 DNA Collection Procedure  
A sample of saliva was obtained using the Oragene.DNA self-collection kit 
(http://www.dnagenotek.com). All preterm samples were recruited through the pathway as 
outlined in 2.1 and had imaged-linked data. Additional term DNA samples to ensure adequate 
numbers of sex-matched controls for the methylation array were provided by Dr Chinthika 
Piyasena from a parallel study which had informed consent and used the same collection 
procedure.  
2.3.2 DNA Sample Storage  
The Oragene DNA saliva samples are stable at room temperature for 5 years. After collection 
by the research nurse, each sample was assigned a study code number and taken to the 
secure, swipe-access, genomic laboratory, where they were stored in locked facilities. Only 
the neonatal research fellows and chief investigator have access to the identification code, 
which is stored in a secure office within the Neonatal Department in the Royal Infirmary of 
Edinburgh.   
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2.4 Molecular Procedures  
2.4.1 DNA Extraction  
Salivary DNA was collected from participating infants as detailed in 2.9.1.  
The resulting Oragene DNA collection pots containing collection sponges and stabilisation 
fluid were mixed gently by inversion and incubated at 50 ºC for 2 hours. The free liquid was 
removed with sterile pipette tips and transferred to a conical centrifuge tube. The barrel of a 
disposable syringe was placed in the centrifuge tube and, using sterile forceps, the sponges 
transferred in to the syringe. This was then centrifuged at 1000rpm for 10 minutes at 20 ºC. 
The volume of solution was noted and a 25th volume of PT-L2P was added and vortexed. The 
sample was incubated on ice for 10 minutes, then centrifuged at 3500rpm for 10 minutes at 
RT. The clear supernatant was transferred into a fresh centrifuge tube with a sterile pipette 
and 1.2 x volume of 100% ethanol (EtOH) was added. It was mixed by inversion and sat at RT 
for 10 minutes. It was centrifuged at 3500rpm for 10 minutes at RT. The supernatant was 
removed & discarded, taking care to not disturb the DNA pellet. 1mL of 70% EtOH was added 
for 1 minute then removed. The DNA was rehydrated in 0.2mL of TE and vortexed for 30 
seconds. It was incubated at RT on a rotating mixing wheel overnight. The supernatant was 
transferred to a 1.5mL microcentrifuge tube and stored at 4 ºC.  
2.4.2 DNA Quantification  
DNA samples were quantified using the Qubit™2.0 Fluorometer with dsDNA HS assay kit. The 
Qubit™ Working Solution was prepared by diluting the Qubit™ Reagent 1:200 in Qubit™ 
buffer. 190µL of working solution and 10 µL of standard solution was combined as a control. 
198 µL of working solution and 2µL of rehydrated patient DNA sample were combined per 
participant. Tubes were vortex 3 seconds and incubated at RT for 2 minutes before insertion 
in to the Qubit™2.0 Fluorometer for measurement.   
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2.4.3 DNA Qualification 
All DNA samples were visualised using gel electrophoresis. A 1% agarose gel was made as 
described in 2.4. 2 µL DNA samples were combined with 2 µL of Glycerol Orange. A 100Bp 
DNA Ladder combined with Glycerol Orange was used as reference. Samples were ran in TBE 
0.5 at 100 volts for 50 minutes. The DNA was visualised using Gel-Doc at 260nm. A thick DNA 
band without RNA smearing was considered a good quality sample. This is demonstrated in 
figure 2.2.  



















2.5 DNA Methylation  
2.5.1 DNA Methylation Array  
The extracted DNA from subjects was passed to a team at the Edinburgh Clinical Research 
Facility, Western General Hospital, to conduct an Illumina HumanMethylation 450 Beadchip 
array.  
The process involves bisulphite conversion, DNA amplification, hybridization and single base 
extension and finally an immunohistochemical assay, which allowed DNA methylation to be 
expressed as a value from 0 to 1.  
2.5.2 Bioinformatics Processing of DNA Methylation Array Data  
The resulting data from the Methylation array was transferred to Dr Jon Manning, for 
bioinformatics processing with use of the RnBeads v0.99.17 package. The process involved 
pre-processing, normalisation and determination of differential methylation.  
Pre-processing made use of the Chen annotation (Chen et al, Epigenetics 2013), which 
removes probes if their CpG loci overlapped with a known SNP identified in the 1000 
Genomes Project (www.1000genomes.org), if a SNP occurred at a single-base extension site, 
if the probe was non-specific or unreliable.  
Normalisation was completed using the method described by Teschendorff (Teschendorff AE 
et al, 2013) which considers distributions of Type I and Type II probes. A batch correction was 
applied using ComBat and then further probes removed if they occurred on sex chromosomes 
or in non CpG areas.  
Differential methylation between the preterm and term infants was assessed using Limma in 
gene promotors (1.5 kb upstream to 0.5 kb downstream of the transcription start site) and 
gene bodies. A generalisation of Fisher’s method with FDR correction (p value <0.05) 
generated genes with significantly differentially methylated regions (DMR), methods as per 
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Smyth GK, 2005.  Gene function was established using the National Center for Biotechnology 
Information Gene database (http://www.ncbi.nlm.nih.gov/gene/about-generif). 
2.6 Pyrosequencing  
2.6.1 Bisulfite Conversion  
All samples were bisulfite converted using the EZ DNA Methylation-Gold
TM 
Kit. The 
concentration of DNA in ng/μl varied for any given sample. The CT conversion reagent and 
M-Wash Buffer were prepared according to Manufacturer’s instructions. 130μl of the CT 
Conversion Reagent was added to 20μl of the DNA sample of interest in a PCR tube, then 
centrifuged briefly. The samples were placed in a thermal cycler with heating to 98°C for 10 
minutes, 64°C for 2.5 hours and then cooling to 4°C overnight.  
600μl of M-Binding Buffer was then added to a Zymo-Spin™ IC Column along with the full 
heat treated DNA sample, the column placed in a collection tube and the solutions mixed by 
inversion. It was then centrifuged at 10000rpm for 30 seconds. The follow through was 
discarded. 100μl of M-Wash Buffer was added to the column and centrifuged at full speed for 
30 seconds. 200μl of M-Desulphonation Buffer was added to the column and incubated at RT 
for 20 minutes. The samples were then centrifuged at full speed for 30 seconds. The samples 
were washed twice with 200μl of M-Wash Buffer to the column followed by centrifugation at 
full speed for 30 seconds. The column was then removed and placed into a microcentrifuge 
tube. 10μl of M-Elution Buffer was added to the column and centrifuge for 30 seconds at full 








2.6.2 PCR Amplification  
Forward and reverse primers for each of the five genes of interest were designed by Dr Mandy 
Drake, using the Pyromark Assay Design 2.0 Software. Assays were purchased from 
Invitrogen, UK and are shown in table 2.1.   
Primers were eluted in DNA free water according to the nmol concentration provided by the 
manufacturer to give a 100µM primer stock solution. For example, for a 20.91 nmol primer, 
10X DNA free water (209µL) was added. Then, 4µL of forward and 4µL of reverse primers 
were combined with 192µL of DNA free water. For each sample a mix of 5µL Amplitaq Gold 
360 Master Mix, 2µL of primer solution, 0.5µL of bisulfite converted DNA and 2.5µL of DNA 
free water was made up. A water control substituted the DNA for 0.5 µL of DNA free water.  
A thermal cycle included initialisation at 95°C for 10 minutes, then 45 cycles of denaturation 
at 95°C for 20 seconds, annealing between 56-58°C for 20 seconds (according to primer’s 
optimal annealing temperature) and extension at 72°C for 20 seconds. A final elongation was 
at 72°C for 7 minutes followed by cooling to 4°C for storage.  
 
Optimal annealing temperature was determined for each primer by an optimisation PCR run 
using a gradient of 55-59°C and qualification by gel electrophoresis as described in 2.10.3. The 
water control was run at the same time to ensure no contamination and a 100Bp DNA ladder 
was used for comparison. Optimal annealing temperature was gauged by strength of DNA 







Table 2.1 Primer design for pyrosequencing validation of methylation array 




NPBWR1 AGA GTT TTT TAT TAT 
TTT AGA TGG AGT 
GAG 
Biotin- CCC CCA AAT 
TTA AAA AAT TCC TTT C 
GAT GGA GTG 
AGG TTG 
QPRT TTG GGA GTT TTG 
GTT TTG AGT 
Biotin - ACA AAA AAA 
ATA TCC CTT TAC CTT 
CA 
AGA TAG TTG 
TAA GTT ATT 
ATG G 
SLC1A2 GTT ATT TAG TTA GAA 
GGT GGT GAA GAA 
Biotin - ACC AAA AAA 
ACC CAA ATC CCA ACA 
AA 
GTG GTG AAG 
AAT TTA AGT TT 
APOL-1 TTT GGT TAT GAG TTG 
TTG GGA AGT T 
Biotin - ACA AAT CCT 
CCA ATC CCC AAA ATA 
TAC 
GGG AAG TTG 
TGA TTT TTA 
SLC7a5 
(assay 1) 
TGT GTG TTT TTT ATA 
GGG TAT GAG G 
Biotin - AAA ACA CTC 
CTA TAT CCC CCT CT 
TTT TTA TAG 
GGT ATG AGG T 
SLC7a5 
(assay 2) 
GAG GAT GAT AGG 
TTG GGG AAG TTG 
Biotin - ATA ACT ACC 
CTA ACC TCT ATC CAT 
CTG TGT TGG 




2.6.3 Pyrosequencing  
Pyrosequencing was completed using the PyroMark Q24 system with the assistance of Dr 
Jessy Cartier. The PyroMark processing file was prepared ahead of time using PyroMark Q24 
software. An illustration of this is shown in figure 2.3 below. This allowed for calculation of 
appropriate enzyme, substrate and nucleotide volumes for loading of the Pyromark Cartridge, 
as shown in figure 2.4 below.  
The appropriate buffers were allowed to warm to RT and the enzyme and substrate mixes 
were reconstituted from the Gold 24 Reagent Kit as per manufacturer’s instructions. 
Sequencing primers for each gene of interest were prepared with 970 µL of annealing buffer 
and 30 µL of 10µM primer.  
The PyroMark plate was loaded with DNA, random DNA and water control binding mixes. For 
DNA samples 2µL of sepharose beads, 40µL of binding buffer, 18µL of DNA free water and 
20µL of PCR amplified product from 2.12.2 were combined and vortexed at RT for 10 minutes 
at 1400rpm. For DNA random controls, the PCR product was replaced with 20µL of a random 













Figure 2.3 Organisation of the PyroMark processing file  
 
 1 2 3 4 5 6 







position  1 assay file 1 assay file 1 assay file 
 2 assay file 2 assay file 2 assay file       
A 
DNA WATER SEQ DNA WATER SEQ 
             
 QPRT CpG  QPRT CpG  QPRT CpG  SLC1A2 CpG SLC1A2 CpG SLC1A2 CpG 







       assay file assay file assay file 
B 
DNA WATER SEQ DNA WATER SEQ 
             
 
Figure 2.4 Illustration of the PyroMark Q24 cartridge  
















2.7 Laboratory Materials  
2.7.1 General Chemicals  
Agarose powder       Bioline, UK 
Boric Acid        Sigma-Aldrich Ltd., UK 
Ethanol        VWR International, UK  
Ethylenediaminetetraacetic acid    Sigma-Aldrich Ltd., UK 
GelRed Nucleic Acid Stain     Biotium, USA  
Gycerol       Sigma-Aldrich Ltd., UK 
Orange G       Sigma-Aldrich Ltd., UK 
Potassium Hydroxide      Sigma-Aldrich Ltd., UK 
Sodium Chloride      Sigma-Aldrich Ltd., UK 
Trizma® base       Sigma-Aldrich Ltd., UK 
Trizma® hydrochloride solution    Sigma-Aldrich Ltd., UK 
      
2.7.2 Molecular Biology  
Amplitaq Gold 360 Master Mix Applied Biosystems, Life 
Technologies, UK 
DNA 100Bp Ladder      Invitrogen, USA  
EZ DNA Methylation Gold Kit including: Zymo Research Corporation, USA 
Zymo-Spin™ IC Column 
Collection tubes 
CT Conversion Reagent 
M-Dilution Buffer 







Gold 24 Reagent Kit Substrate Mix    Qiagen, UK 
Gold 24 Reagent Kit Enzyme Mix    Qiagen, UK 
PCR amplification Primers     Invitrogen, UK  
PrepIT L2P solution       DNA Genotek, Canada 
 
Pyromark Binding Buffer Qiagen, UK 
Pyromark Annealing Buffer  Qiagen, UK 
Pyromark Wash Buffer     Qiagen, UK 
Pyromark Denaturation Buffer    Qiagen, UK 
Pyromark A, T, C, G nucleotides     Qiagen, UK 
Qubit DNA High Sensitivity Assay Kit    Life Technologies, USA  
Streptavidin Sepharose beads    GE Healthcare, Sweden 




2.8 Laboratory Equipment  
Bench Centrifuge 5424 & 5415R    Eppendorf, Germany 
8 strip PCR tubes       Star Lab, UK 
Falcon Conical centrifuge tubes    BD Biosciences, UK 
G-Storm thermocycler     Labtech International, UK  
Hybridisation Oven (Techne Hybridiser HB-1D)  Bibby Scientific Ltd, UK  
IKA MS 3 Basic Shaker      IKA – Werke, Germany 
Microcentrifuge tubes      Sigma-Aldrich Ltd., UK 
Milli-Q integral water purification system   EMD Millipore, USA  
Nanodrop ND-1000 Spectrophotometer    ThermoScientific, USA  
Orbital Shaker       Voss Instruments, Maldon UK  
Oragene OG-250 kits with saliva sponges CS-1  DNA Genotek, Canada  
Pipettes p2, p20, p200, p1000    Gilson, UK 
Pipette Tips        StarLab, UK  
Power Pac 300       Biorad Laboratories Inc., UK  
PyroMark Q24 system     Qiagen, UK  
Pyrosequencing Technology     Biotage AB, Sweden  
Qubit 2.0 Fluorimeter      Life Technologies, USA  
Rotamixer Vortex      Hook and Tucker Instruments, 
UK 
Sterile Disposable Forceps (Griprite Blue)   Rocialle, UK 
Sterile Disposable syringe     BD Biosciences, UK  
Sub-cell 96 electrophoresis tank    Biorad Laboratories Inc., UK 
Transilluminator      UVitec, UK 
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2.9 Laboratory Software 
ND-1000 v3.3 NanoDrop Technologies, Thermo 
Fisher Scientific, UK  
SPSS Statistics 21 International Business Machines 
Corporation (IBM), USA  





2.10 Laboratory Solutions  
Agarose gel 0.5g of 1% agarose powder was placed in 50mls TBE and heated to dissolve. 3µl 
of GelRed Nucleic Acid Stain was then added to the solution and it was set in a cool room.  
0.5M EDTA pH 8.0 186.1g of EDTA (disodium ethylenediamine tetraacetate.2H2O) was 
dissolved in 800mls of MilliQ water. The pH was then adjusted to 8.0 using 10M KOH and final 
volume made up to 1 litre with MilliQ water. The solution was autoclaved and stored at room 
temperature. 
Orange G 30ml of glycerol and 0.25g of Orange G powder were combined and made up to 
100ml with Polymerase Chain Reaction (PCR)-grade water.  
10 x TBE 108g of tris base, 55g of boric acid and 40ml of 0.5M EDTA were combined, then 
made up to 1litre with MilliQ water to give Tris/Borate/EDTA (TBE). The solution was 
autoclaved and stored at room temperature.  
0.5 x TBE 50ml of 10 X TBE was diluted in 950mls of MilliQ water. The solution was stored at 
room temperature.  
TE 3.5ml of 1M Tris (pH 7.5) and 0.5ml of 0.5M EDTA was combined and made up to 250ml 





2.11 MRI Equipment  
MRI compatible ECG leads  
MRI compatible Neonatal Saturation Probe  
MRI compatible physiological monitoring  
Soft Foam Ear plugs  
MiniMuff Ear protection       Natus Medical, USA 
Siemens MAGNETOM Verio 3T MRI clinical scanner  Siemens Healthcare 
Germany 








2.12 MRI Software 
FSL (FMRIB Software Library v5.0) Analysis Group, FMRIB, UK 
MATLAB  Mathworks, USA  







Chapter 3: DTI Imaging of Preterm Infants: Risk and Resilience 
Factors 
3.1 Introduction 
3.1.1 Introduction  
Preterm birth is associated with neurodevelopmental impairment including cerebral palsy, 
cognitive deficits, and behavioural problems including attention deficit, ASD and increased 
risk of later life psychiatric disease. 14% of very preterm infants (gestational age less than 32 
weeks) have moderate to severe disability (Larroque B et al, 2008) and preterm infants have 
an increased risk of brain injury, with up to 50% of very low birth weight (less than 1500 
grams) showing signs of diffuse white matter injury on MRI (Khwaja O & Volpe JJ, 2008). 
Clinically, as well as gestational age and birthweight there are factors which are deemed 
neuroprotective or neurotoxic with regards to long term neurodevelopmental outcome. 
Postnatal infection (Stoll BJ et al, 2004 & Mitha A et al, 2013), bronchopulmonary dysplasia 
(Majnemer A et al, 2000; Boardman JP et al, 2007; Ball G et al, 2010) and the presence of 
clinical or histological chorioamnionitis (HCA) (Shatrov JG et al, 2010; Soraisham AS et al 2013, 
Ylijoki M et al 2016, Anblagan D et al, 2016) have all been shown to have a negative effect on 
neurodevelopment. The antenatal administration of corticosteroids (Sotiriadis A et al, 2015) 
and magnesium sulphate (Doyle LW et al, 2009) have been shown to have a positive effect on 
neurodevelopment.  
The pathogenesis of preterm white matter injury is multifactorial and involves mechanisms 
such as hypoxia, ischaemia, free radical damage and infection which ultimately lead to death 
or disruption of the pre-myelinating oligodendrocyte (Volpe JJ, 2011) and abnormalities in 
white matter micro and macro-architecture. Diffusion tensor imaging allows quantitative 
interrogation of the white matter microarchitecture by mapping the diffusion of water 
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through regions of interest or specific neuronal tracts. Three regions of white matter with 
significant roles in cognitive and motor function are the corpus callosum, the posterior limb 
of internal capsule and the centrum semiovale.  
The outcome measures FA (fractional anisotropy) and MD (mean diffusivity) give an indication 
of white matter organisation, myelination and development (Huppi PS & Dubois JS, 2006). FA 
and MD are dynamic throughout neurodevelopment (Huppi et al, 1998) and decreased FA 
and increased MD at term equivalent age is associated with white matter injury (Counsell et 
al, 2006) and poorer neurodevelopmental outcome (Arzoumanian et al 2003, Boardman et al 
2010, Krishnan et al 2007, Rose et al 2007, Bassi et al 2008, Counsell et al 2008, Kontis et al, 
2009, Thompson et al, 2011). Therefore, DTI measurements can be described as quantitative 
biomarkers of preterm brain injury which are predictive of neurodevelopmental outcome 




3.1.2 Hypotheses and Aims 
I hypothesised that would be a significant difference in FA and MD in brain white matter tracts 
in preterm infants at term equivalent age when compared to term controls. FA should be 
reduced in preterm infants compared to term controls and MD increased. Using precedence 
in the literature of preterm at TEA and term control imaging studies (Boardman JP et al, 2010) 
I aimed to collect DTI data on 80 preterm and 20 term control subjects.  
I assessed this by performing DTI scans on preterm infants at term equivalent age and term 
control infants. Subsequent data were analysed using the ROI method within 5 regions-of-
interest, the genu of the corpus callosum, the posterior limb or internal capsule and the 
anterior, central and posterior centrum semiovale (CSO).  
I also hypothesised that there would be a beneficial effect, quantifiable at the microstructural 
level of white matter development in preterm infants, at term equivalent age, with the use 
of the antenatal neuroprotective agent - magnesium sulphate.  I also expected to see a 
deleterious effect, associated with clinical states which are known to be associated with 
poorer neurodevelopmental outcome in preterm infants, including bronchopulmonary 
dysplasia, and chorioamnionitis (as defined by histological examination of the placenta). I 
chose not to investigate late onset sepsis due to the difficulty in defining its presence clearly, 
and antenatal corticosteroids due to the large discrepancy between preterm infants who 
were exposed versus not exposed in this population.  
I aimed to investigate these independent factors by statistical analysis of the preterm cohort 





3.2 Methods  
3.2.1 Demographic Data Collection 
With maternal consent, maternity notes were interrogated for maternal age and BMI (weight 
in kilograms/height in metres2) at booking, preconception folic acid, use of artificial 
reproductive therapy (ART), maternal past medical history, multiple gestation, birthweight 
(kilograms) and gestational age of infants at birth, gender, IUGR (defined as birthweight less 
than 3rd centile for gestational age), mode of delivery, exposure to antenatal magnesium 
sulphate and corticosteroids (with a complete course defined as two doses of Betamethasone 
12mg given 24hrs apart, before delivery).  The presence of HCA was determined by maternal 
placental pathology report (not available for routine term delivery) which classifies the 
presence of HCA as an inflammatory response in the placental membranes of any grade or 
stage. With parental consent, infant notes were interrogated for bronchopulmonary 
dysplasia (BPD), defined as an oxygen requirement at 36 weeks corrected gestation, late-
onset sepsis (LOS), defined as clinical instability requiring treatment with at least 5 days of 
antibiotics and a positive blood culture, and necrotising enterocolitis (NEC) if characterised as 
Bell Stage 2 or above. At time of scan, infants were weighed (kilograms) and had their occipital 
frontal circumference (OFC) of head measured, corrected gestational age (PMA) calculated 
and exposure to breast milk was determined.  
3.2.2 MRI Scanning  
All infants underwent the pre-MRI procedure as outlined in methods 2.2.1 and once asleep 
were taken to the MRI scanner and underwent the MRI scan protocol as detailed in methods 




3.2.3 MRI Data Processing  
Structural images were assessed offsite by Dr A G Wilkinson, a paediatric radiologist with 
experience in neonatal MR imaging. Results were reported to the families and made available 
in clinical notes. If there was unexpected cystic PVL or (haemorrhagic parenchymal infarction) 
HPI reported on structural imaging, the infants were excluded from the study. Data was 
stored and processed as per methods 2.2.3 and 2.2.4 with new study codes generated at this 
stage to allow blinding.  
3.2.4 ROI Analysis  
As described in methods 2.2.5.1 DTI images were visualized in the axial plane in 2mm slices 
using FSL viewer with best slice for each gCC, left and right PLIC and left and right anterior, 
central and posterior CSO identified. Images were interpolated post-acquisition. Diffusion 
values (MD and FA) were manually extracted from a 1mm3 ROI placed at the centre of each 
ROI and calculated using a MATLAB algorithm.  Data were reviewed after analysis and 
significant outliers were reanalysed.  
In order to avoid bias, I was blinded to the gestational age and clinical state of the infants at 
the ROI analysis stage.  
3.2.5 Statistical Analysis  
Data were analysed using SPSS Statistics version 21 (International Business Machines 
Corporation (IBM), USA). Data were checked for normality of distribution and homogeneity 
of variance. For analysis of demographic data and bivariate analysis of the effect of 
independent variables on FA and MD, and univariate analysis of the difference in independent 
variables between patient groups: independent t tests were used for continuous data and CHI 
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squared analysis for categorical data. For analysis of DTI parameters between left and right 
hemispheres, paired t testing was used. A multiple regression model was used to assess the 
effect of independent variables between patient groups after correction for GA at birth and 
PMA at time of scan. Type 1 error was controlled using false discovery rate (FDR) (p < 0.05). 
3.3 Results  
3.3.1 Patient Recruitment Pathway  
A consort diagram from assessment of eligibility to individual subjects with available DTI data 
is shown in figure 3.2 below. There were 229 preterm infants with a birthweight of less than 
1500 grams or a gestational age at birth of less than 32 weeks within the study period of 
January 2012 to April 2014. 61 infants (26.6%) did not meet inclusion criteria and a further 17 
(7.4%) met exclusion criteria. Of the 151 preterm infants eligible for consent 151 (100%) were 
approached and 99 (65.6%) consented. Data were not collected on the number of term 
infants approached for consent, but 26 gave written consent during the study period.  
After consent, DTI data were not captured on a subsequent 28 infants, with the main reasons 
being infants were too unwell to present for MRI scan (21.4%) or did not sleep throughout 
the scan (42.8%). Severe movement artefact, as demonstrated in figure 3.1, prevents the 
capture of diffusion data and therefore these infants were excluded post consent. However, 
for those infants who presented for MRI which included the DTI protocol (n= 109) the majority 
(n= 97, 89%) had DTI data captured of sufficient quality for analysis, with n= 12, 11% DTI scans 




Figure 3.1 T1 weighted images showing a) moderate and b) severe movement artefact 
(anonymised images from Clinical Research Imaging Centre, Edinburgh UK) 
 
     
b.  a.  
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Preterm Infants  
<1500grams or <32 weeks within 
Simpson Centre for Reproductive 
Health (Jan 2012 to April 2014) 
(n= 229) 
Term Infants  
>1500 grams and >37 weeks within 
Simpson Centre for Reproductive 
Health (Jan 2012 to April 2014) 
Preterm Infants not consented (n= 52) 
Declined to participate (n= 48) 
Social reasons unable to gain consent (n= 4) 
 
 
Excluded post consent (n= 28) 
Pilot study, no DTI protocol (n= 2) 
Did Not Attend MRI scan (n= 5) 
Withdrew consent (n= 2) 
Too unwell to scan (n =6) 
Subsequent genetic diagnosis (n= 1) 
 
Unsettled, no DTI available:  
(Preterm n =5, Term n= 7) 
 
Excluded after DTI capture (n= 2) 
Subsequent PVL diagnosed (n= 1) 
DTI data lost (n= 1) 
DTI CAPTURE 
Preterm n= 78 
Term n= 19 
CONSENTED  
Preterm n= 99 
Term n= 26 
DTI ANALYSIS 
INFANTS WITH DTI DATA 
Preterm n= 76 
Term n= 19 
Did not meet inclusion criteria (n = 61) 
Died (n= 17) 
Transferred out of region (n= 32) 
Too unwell for MRI scan (n= 8) 
No MRI slots available (n= 4) 
 
Met exclusion criteria (n = 17) 
Cystic PVL or grade IV IVH (n= 8) 




Preterm = 151 




3.3.2 Demographics  
The demographics of infants with available DTI data from MRI scanning (n= 95) are shown in the 
table 3.1. As expected, there is a significant difference between preterm and term infants with 
regards to birthweight (3.41Kg versus 1.16 Kg, p <0.001) and gestational age (39.6 weeks versus 
29.27 weeks, p <0.001) at birth. There are also significant differences in growth of the preterm 
population at term corrected age, with preterm infants having significantly smaller OFC (36.2cm 
versus 34.6cm, p <0.001) and weight (3.75Kg versus 2.85 Kg, p <0.001). There was also a 
significant difference in corrected gestational age at time of scan between term and preterm 
infants (42.45 weeks versus 39.85 weeks, p <0.001) and therefore subsequent analysis was 


















Table 3.1. Demographics of Infants with ROI Analysed DTI Data   
 
  
Term Infants  
n = 19 
Preterm Infants  
n = 76 
p value 
 
Birthweight (Kg)* 3.41 (2.87 to 4.26) 1.16 (0.55 to 1.635) <0.001 
Gestational Age at Birth  
(decimal weeks) * 39.6 (38.14 to 41.7) 29.27 (23.29 to 34.86) <0.001 
Corrected Gestational Age at Scan 
(decimal weeks) * 42.45 (39 to 47.14) 39.85 (37.28 to 42.71) <0.001 
Weight (Kg) at Sample* 3.75 (2.91 to 4.83) 2.85 (2.06 to 3.78) <0.001 
OFC (cm) at Sample* 36.2 (32.6 to 39.5) 34.6 (31.0 to 38.0) <0.001 
Female** 11 (57.8) 37 (48.6) 0.505 
Maternal Age * 33 (19 to 45) 31 (17 to 44) 0.245 
Maternal BMI* 25.1 (19.7 to 36.4) 25.7 (18 to 43) 0.662 
Preconception Folic Acid** 10 (52.6) 33 (43.4) 0.5 
Diabetes (Gestational or IDDM)** 0 (0) 7 (9.2) 0.166 
Multiple Birth** 0 (0) 28 (36.8) 0.001 
Severe IUGR** 0 (0) 6 (7.9) 0.206 
ART** 1 (5.2) 15 (19.7) 0.338 
Chorioamnionitis** 0 (0) 24 (31.6) n/a 
Exposure to Antenatal Steroids** 0 (0) 71 (93.4) n/a 
Exposure to Magnesium 
Sulphate** 0 (0) 36 (47.3) n/a 
Vaginal Delivery** 11 (57.8) 26 (34.2) 0.058 
BPD ** 0 (0) 20 (26.3) n/a 
NEC** 0 (0) 3 (3.9) n/a 
Late-onset sepsis**  0 (0) 17 (22.4) n/a 
Breast Milk** 16 (84.2) 56 (73.6) 0.338 
Caucasian Origin  18 (94.7) 70 (92.1) n/a 
African Origin  0 (0) 2 (2.6) n/a 
Asian Origin  1 (5.3) 4 (5.3) n/a 
 
* Mean (range) 
** Number (percentage) 
ART = Artificial Reproductive Therapy 
Severe IUGR = Birthweight below the 3rd centile for gestation  
BPD = bronchopulmonary dysplasia defined as an oxygen requirement at 36 weeks corrected  
NEC = necrotising enterocolitis, Bell Stage II or above  
Late-onset sepsis = Clinical instability requiring antibiotics with a positive blood culture  







3.3.3 Analysis of Left and Right Hemispheric Data  
White matter regions of interest which included right and left sided data were analysed to 
assess significance between hemispheres. This data is presented in the tables 3.2 and 3.3. 
There were no significant differences for FA or MD (x10-3mm2/s) between right and left 
hemispheric data within the frontal, central or posterior white matter and within the right 
and left PLIC.  
Quantitative measurements were therefore combined and averaged in each individual to give 
regions of interest as Frontal CSO, Central CSO, Posterior CSO and PLIC.  
Table 3.2: Analysis of Left and Right Hemispheric FA Measurements 
  Mean Std. Deviation p value  
Right Frontal CSO FA  0.126 0.052 0.555 
Left Frontal CSO FA 0.123 0.056   
Right Middle CSO FA  0.142 0.053 0.059 
Left Middle CSO FA  0.153 0.058   
Right Posterior CSO 
FA  0.186 0.058 0.088 
Left Posterior CSO FA  0.175 0.063   
Right PLIC FA  0.422 0.052 0.987 
Left PLIC FA 0.422 0.057   
 
Table 3.3: Analysis of Left and Right Hemispheric MD Measurements 
  Mean (x 10-3 mm2/s) 
Std. Deviation 
(x 10-3 mm2/s) p value  
Right Frontal CSO MD 1.636 0.177 0.832 
Left Frontal CSO MD 1.633 0.182   
Right Middle CSO MD 1.564 0.191 0.686 
Left Middle CSO MD 1.559 0.194   
Right Posterior CSO 
MD 1.537 0.203 0.283 
Left Posterior CSO 
MD 1.523 0.184   
Right PLIC MD 1.034 0.06 0.213 




3.3.4 The Effect of Prematurity on White Matter Microstructure  
On bivariate analysis, there was a significant reduction in FA and significant increase in MD 
(x10-3mm2/s) in all white matter regions of interest in preterm infants at term equivalent age 
compared to term controls. These results are displayed in Figures 3.3 and 3.4.  
After correction for PMA at scan, FA was reduced in preterm infants at term equivalent age 
compared with term controls in the genu (B 0.128 [95% CI 0.091 to 0.166], p <0.001), PLIC (B 
0.029 [95% CI 0.006 to 0.052], p = 0.016) and frontal CSO (B 0.037 [95% CI 0.012 to 0.062], p 
= 0.04). Preterm birth did not determine FA in the central CSO (B 0.002 [95% CI -0.023 to 
0.027], p = 0.894, whereas PMA at scan does (B 0.014 [95% CI 0.008 to 0.019], p <0.001) and 
the posterior CSO (B 0.028 [CI -0.001 to 0.057], p = 0.062), whereas PMA at scan does (B 0.007 
[95% CI 0.001 to 0.013], p =0.031).  
After correction for PMA at scan, MD (x10-3mm2/s) was increased in preterm infants at term 
equivalent age compared with term controls in the frontal CSO (B -0.171 [95% CI -0.257 to -
0.084], p <0.001), central CSO (B -0.096 [95% CI -0.188 to -0.004], p =0.041) and the posterior 
CSO (B -0.134 [95% CI -0.237 to -0.30], p=0.012). Preterm birth did not determine MD (x10-
3mm2/s) in the genu (B -0.046 [95% CI – 0.146 to 0.054], p = 0.359), whereas PMA at scan does 
(B -0.025 [95% CI -0.047 to -0.004], p = 0.020), or the PLIC (B -0.004 [95% CI -0.035 to 0.027], 
p = 0.814), whereas PMA at scan, does (B -0.011 [95% CI -0.017 to -0.004], p =0.002).  









Note: FA – Fractional Anisotropy, MD – Mean Diffusivity, PLIC – Posterior Limb of Internal 
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Figure 3.4 The effect of prematurity on MD
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 Table 3.4 Mean (SD) for mean diffusivity (MD) and fractional anisotropy (FA) in all 












PLIC 0.41 (0.043) 0.465 (0.029) <0.001 0.016 
Genu 0.359 (0.054) 0.5 (0.083) <0.001 <0.001 
Frontal CSO  0.112 (0.039) 0.173 (0.057) <0.001 0.004 
Central CSO 0.139 (0.047) 0.178 (0.049) 0.002 0.894 
Posterior CSO 0.171 (0.051) 0.217 (0.04) <0.001 0.062 
 Mean diffusivity MD (×10−3 mm2 /s) 
 
Preterm 






PLIC 1.046 (0.05) 1.013 (0.068) 0.01 0.814 
Genu 1.405 (0.141) 1.282 (0.201) <0.001 0.359 
Frontal CSO  1.687 (0.154) 1.454 (0.1) <0.001 <0.001 
Central CSO 1.612 (0.17) 1.402 (0.115) <0.001 0.041 
Posterior CSO 1.567 (0.173) 1.391 (0.165) 0.022 0.012 
 
Note:-  
FA – Fractional Anisotropy, MD – Mean Diffusivity, PLIC – Posterior Limb of Internal Capsule,  




3.3.5 The Effect of Antenatal Magnesium Sulphate Exposure on White Matter 
Microstructure in Preterm Infants  
36 (47.3%) of the preterm group had been exposed to antenatal MgSO4. On bivariate analysis, 
this was not associated with a significant difference in FA or MD (x10-3mm2/s) at term 
equivalent age, in any white matter region-of-interest.  These data are presented in figures 
3.5 and 3.6.  
GA birth differed significantly (p =0.01) in infants who had been exposed to antenatal MgSO4 
[mean GA 28.6 ± 1.73 weeks] compared to those who had not [mean GA 29.9 ± 2.42 weeks].  
After correction for GA at birth and PMA at time of scan, in multiple  analysis, antenatal MgSO4 
was associated with a significant increase in FA in the genu (B -0.30, [95% CI -0.055 to -0.004], 
p = 0.023).  
In all other areas analysed, after correction for GA at birth and PMA at time of scan, in multiple  
antenatal MgSO4 was not associated with a significant difference in FA (PLIC: B -0.011, [95% 
CI -0.030 to 0.008], p = 0.239, Frontal CSO: B -0.006, [95% CI -0.025 to 0.012], p = 0.483, 
Central CSO: B 0.002, [95% CI -0.017 to 021], p = 0.82, Posterior CSO: B -0.008, [95% CI -0.032 
to 0.017], p = 0.538) or MD x 10-3 mm2/s (genu: B -0.057, [95% CI -0.016 to 0.130], p = 0.125, 
PLIC: B 0.011, [95% CI -0.01 to 0.032], p = 0.304, Frontal CSO: B -0.018, [95% CI -0.09 to 0.055, 
p = 0.63, Central CSO: B 0.012, [95% CI -0.062 to 0.087], p = 0.746, Posterior CSO: B 0.049, 
[95% CI -0.033 to 0.132], p = 0.237].  







Note: FA – Fractional Anisotropy, MD – Mean Diffusivity, PLIC – Posterior Limb of Internal 
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Table 3.5 Mean (SD) for mean diffusivity (MD) and fractional anisotropy (FA) in all 





MgSO4 (n = 36) No MgSO4 (n= 40)  Unadjusted p-value  
Adjusted  
p-value 
PLIC 0.413 (0.040) 0.409 (0.046) 0.693 0.239 
Genu 0.37 (0.055) 0.352 (0.055) 0.16 0.023 
Frontal CSO  0.114 (0.047) 0.111 (0.031) 0.733 0.483 
Central CSO 0.135 (0.048) 0.145 (0.043) 0.328 0.82 
Posterior CSO 0.174 (0.049) 0.169 (0.053) 0.689 0.538 
 Mean diffusivity MD (×10
−3 mm2 /s) 
 
MgSO4 (n = 36) No MgSO4 (n= 40)  Unadjusted p-value  
Adjusted  
p-value 
PLIC 1.04 (0.04) 1.04 (0.06) 0.989 0.304 
Genu 1.38 (0.13) 1.41 (0.18) 0.394 0.125 
Frontal CSO  1.7 (0.16) 1.66 (0.15) 0.252 0.63 
Central CSO 1.62 (0.15) 1.59 (0.19) 0.508 0.746 
Posterior CSO 1.55 (0.17) 1.58 (0.18) 0.344 0.237 
 
Note:-  
FA – Fractional Anisotropy, MD – Mean Diffusivity, PLIC – Posterior Limb of Internal Capsule,  




3.3.6 The Effect of Bronchopulmonary Dysplasia on White Matter Microstructure in 
Preterm Infants  
20 (26.3%) preterm infants had bronchopulmonary dysplasia (BPD) defined by the need for 
oxygen at 36 weeks corrected gestation. In bivariate analysis, this was associated with a 
significant decrease in FA (mean difference -0.16 [95% CI -0.031 to -0.001], p =0.036) and 
significant increase in MD (x10-3mm2/s) within the frontal CSO at term equivalent age (mean 
difference mean difference 0.091 [95% CI 0.023 to 0.16], p= 0.01). These results are displayed 
in figures 3.7 and 3.8.  
There was no significant difference in PMA at time of scan (p = 0.407) between infants with 
BPD compared to those without. There was a significant difference in gestational age at birth 
(p =0.02) for infants with BPD (28.0 ± 2.16 weeks) compared to those without (29.7 ± 2.1 
weeks).   
After correction for GA at birth and PMA at time of scan, in multiple  analysis BPD was not 
associated with significant changes in FA (genu: B -0.019, [95% CI -0.049 to 0.011], p = 0.207, 
PLIC: B -0.004, [95% CI -0.026 to 0.017], p = 0.706, Frontal CSO: B 0.17, [95% CI -0.004 to 
0.038], p = 0.108, Central CSO: B 0.012, [95% CI -0.010 to 0.034], p = 0.271, Posterior CSO: B  
-0.007, [95% CI -0.035 to 0.021], p = 0.634) or MD x10-3 mm2/s (genu: B 0.043, [95% CI -0.042 
to 0.128], p = 0.312, PLIC: B 0.01, [95% CI -0.023 to 0.026], p = 0.904, Frontal CSO: B -0.072, 
[95% CI -0.154 to 0.009], p = 0.08, Central CSO: B -0.051, [95% CI -0.136 to 0.033], p = 0.231, 
Posterior CSO: B 0.039, [95% CI -0.056 to 0.135], p = 0.416.  







Note: FA – Fractional Anisotropy, MD – Mean Diffusivity, PLIC – Posterior Limb of Internal 
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Table 3.6 Mean (SD) for mean diffusivity (MD) and fractional anisotropy (FA) in all 





BPD (n = 20) No BPD (n = 56)  Unadjusted p-value  
Adjusted  
p-value 
PLIC 0.41 (0.043) 0.411 (0.043) 0.933 0.706 
Genu 0.365 (0.044) 0.359 (0.059) 0.619 0.207 
Frontal CSO  0.101 (0.021) 0.116 (0.044) 0.036 0.108 
Central CSO 0.128 (0.033) 0.145 (0.049) 0.086 0.271 
Posterior CSO 0.175 (0.041) 0.170 (0.054) 0.668 0.634 
 Mean diffusivity MD (×10
−3 mm2 /s) 
 
BPD (n = 20) No BPD (n = 56)  Unadjusted p-value  
Adjusted  
p-value 
PLIC 1.051 (0.042) 1.043 (0.051) 0.501 0.904 
Genu 1.38 (0.091) 1.400 (0.177) 0.539 0.312 
Frontal CSO  1.747 (0.118) 1.656 (0.159) 0.01 0.08 
Central CSO 1.662 (0.135) 1.58 (0.179) 0.038 0.231 
Posterior CSO 1.544 (0.169) 1.573 (0.173) 0.526 0.416 
 
Note: FA – Fractional Anisotropy, MD – Mean Diffusivity, PLIC – Posterior Limb of Internal 
Capsule, genu – Genu of Corpus Callosum, CSO – Centrum Semiovale, BPD – 
















3.3.7 The Effect of Histological Chorioamnionitis on White Matter Microstructure in 
Preterm Infants  
24 (31.6%) preterm infant had confirmed histological chorioamnionitis (HCA) on pathological 
examination of their placentas. On bivariate analysis, the presence of histological 
chorioamnionitis was associated with a significant reduction in FA in the Central CSO (mean 
difference -0.022 [95% CI -0.042 to -0.001], p = 0.037) and a significant increase in MD (x10-
3mm2/s) in the Central CSO (mean difference 0.096 [95% CI 0.020 to 0.172], p= 0.013). These 
data are displayed in figures 3.9 and 3.10.  
There was no significant difference in PMA at time of scan between infants with evidence of 
HCA compared to those without (p =0.076). There was a significant difference in gestational 
age at birth (p <0.001) between infants with HCA (27.9 ± 2.15 weeks) and those without (29.89 
± 1.97 weeks).  
After correction for GA at birth and PMA at time of scan, in multiple  analysis histological 
chorioamnionitis was not associated with changes in FA (Genu: B -0.003, [95% CI -0.033 to 
0.027], p = 0.847, PLIC: B -0.004, [95% CI -0.025 to 0.017], p = 0.703, Frontal CSO: B 0.06, [95% 
CI -0.015 to 0.027], p = 0.56, Central CSO: B 0.012, [95% CI -0.010 to 0.033], p = 0.278, 
Posterior CSO: B -0.004, [95% CI -0.032 to 0.023], p = 0.766) or MD x10-3 mm2/s (Genu: B -
0.18, [95% CI -0.102 to 0.066], p = 0.674, PLIC: B 0.002, [95% CI -0.022 to 0.026], p = 0.885, 
Frontal CSO: B -0.035, [95% CI -0.116 to 0.047], p = 0.4, Central CSO: B -0.051, [95% CI -0.134 
to 0.033], p = 0.232, Posterior CSO: B -0.044, [95% CI -0.138 to 0.05], p = 0.357).  







Note: FA – Fractional Anisotropy, MD – Mean Diffusivity, PLIC – Posterior Limb of Internal 
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Table 3.7 Mean (SD) for mean diffusivity (MD) and fractional anisotropy (FA) in 





HCA (n = 24) No HCA (n = 52)  Unadjusted p-value  
Adjusted  
p-value 
PLIC 0.407 (0.045) 0.413 (0.042) 0.612 0.703 
Genu 0.353 (0.061) 0.364 (0.053) 0.459 0.847 
Frontal CSO  0.106 (0.046)  0.115 (0.036) 0.415 0.56 




(0.048) 0.172 (0.052) 0.979 0.674 
 Mean diffusivity MD (×10−3 mm2 /s) 
 
HCA (n = 24) No HCA (n = 52)  Unadjusted p-value  
Adjusted  
p-value 
PLIC 1.054 (0.037) 1.041 (0.053) 0.223 0.885 
Genu 1.425 (0.712) 1.38 (0.152) 0.286 0.674 
Frontal CSO  1.725 (0.144) 1.659 (0.156) 0.079 0.4 
Central CSO 1.667 
(0.140) 




(0.188) 1.550 (0.163) 0.304 0.357 
  
Note: FA – Fractional Anisotropy, MD – Mean Diffusivity, PLIC – Posterior Limb of Internal 






3.4 Discussion  
Within this chapter, in a population of 76 preterm and 19 term control infants, I have 
confirmed that preterm birth is associated with a reduction in FA and an increase in MD in 
specific white matter regions at term equivalent age.  
Analyses of the preterm cohort, has shown that BPD, HCA and exposure to antenatal MgSO4 
may influence white matter microstructure at term equivalent age, however these results are 
altered by GA at birth and PMA at time of scan.  
DTI measurements of FA and MD were significantly different in all regions of interest in 
preterm infants at term equivalent age compared to term controls in bivariate analysis. 
However, after adjustment for the significantly different PMA at time of scan, which was 
necessary as both FA and MD change rapidly during postnatal development (Huppi PS et al, 
1998), only FA in the gCC, PLIC and frontal CSO and MD in the frontal, central and posterior 
CSO remained significantly different. These data are in agreement with previously published 
ROI studies (Counsell SJ et al, 2006, Rose J et al, 2007 & Skiöld B et al, 2010), which not only 
show significant differences between preterm infants at TEA and term controls in select white 
matter regions, but similar DTI values.  This suggests this study population is representative.  
DTI allows an objective measurement of white matter integrity and has been shown to be 
related to neurodevelopmental outcomes in the preterm population (Arzoumanian Y et al, 
2003, Krishnan ML et al, 2007, Rose J et al, 2007, Boardman JP et al, 2010, & Thompson DK et 
al, 2011). As such, FA and MD in select white matter regions may be used as tools to aid 
prognosis and as biomarkers for the investigation of therapeutic interventions (O’Gorman RL 
et al, 2015).  
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Within the preterm population, I investigated the effect of the antenatal intervention, 
magnesium sulphate. MgSO4 has biological plausibility as a neuroprotective agent due to its 
function as a NMDA receptor antagonist and its role in prevention of calcium related 
excitotoxic injury. It has also been linked to the reduction of inflammatory cytokines and free 
radicals following hypoxic-ischaemic reperfusion, all of which are linked to the pathogenesis 
of preterm white matter injury (Conde-Agudelo A et al, 2009). In addition, there is good 
evidence that it attenuates blood-brain-barrier permeability in models of eclampsia and 
sepsis (Esen F et al, 2005; Euser AG et al, 2008). A systematic review of 5 randomized 
controlled trials has shown that the administration of MgSO4 reduces the incidence of 
cerebral palsy in infants born very preterm (Doyle LW et al, 2009), however long term 
cognitive data are contradictory (Doyle LW et al, 2014).  
After correction for GA at birth and PMA at time of scan, I found a significant increase in FA 
within the gCC in preterm infants who had been exposed to antenatal MgSO4 compared to 
those not exposed. However, as the genu of the corpus callosum connects the right and left 
frontal lobes which contain the prefrontal cortex and the motor cortex, it has a role in both 
motor and cognitive function (Fabri M et al, 2013). In support of this, Anblagan et al has shown 
that antenatal MgSO4 exposure is associated with altered tract shape in the splenium of the 
corpus callosum (Anblagan et al, 2015). These data therefore suggest that MgSO4 has a 
beneficial tissue effect which extends past motor function.  
The other significant antenatal neuroprotective therapy delivered in expectant preterm birth 
is corticosteroids. The administration of antenatal corticosteroids is recommended by the 
RCOG for any woman at risk of preterm delivery (RCOG, 2010), with a complete course in this 
population defined as two doses of betamethasone 12mg, given 24 hours apart. It reduces 
the incidence of respiratory distress syndrome and therefore mortality in preterm infants, but 
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has also been shown to reduce the incidence of intraventricular haemorrhage and white 
matter lesions (Agarwal R et al, 2002) and improve neurodevelopmental outcome (Sotiriadis 
A et al, 2015). However, although repeated doses of corticosteroids do not show any benefit 
or risk to neurodevelopment (Crowther CA et al, 2007), in animal models there is an 
association with reduced myelination (Shields A et al, 2012). Although the mechanism by 
which corticosteroids may be of benefit to neurodevelopment is largely unknown, there is 
some evidence in animal models that they can reverse the effects of inflammatory cytokines 
such as INFγ and TNFα which block the differentiation of oligodendrocyte precursors (Mann 
SA et al, 2008). Within this population, I chose not to analyse the administration of 
corticosteroids as the number of infants without exposure was small (n = 5). A larger study 
population may allow analysis of the effect of this agent in the perinatal period at the 
microstructural level. 
Within the preterm population, I also investigated the effect of histological chorioamnionitis 
and BPD on white matter microstructure at term equivalent age. 
A meta-analysis has demonstrated that both clinical and HCA is associated with cerebral palsy, 
intraventricular haemorrhage and PVL (Shatrov JG et al, 2010) and a further study has linked 
HCA with poorer cognitive outcome at 5 years of age (Ylijoki M et al, 2016). Within this 
population, I chose to measure rates of HCA rather than clinical cases as this is a more 
objective measure of intrauterine infection. 
Although both HCA and BPD initially showed significant differences in defined white matter 
regions-of-interest on bivariate analysis, these results were not significant after correction for 
GA at birth and PMA at time of scan.  
As demonstrated in the preterm versus term control group, GA at birth has a significant effect 
on white matter microstructure and both FA and MD are dependent on the PMA at time of 
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scan. Future work with groups which are more closely matched in terms of PMA at time of 
scan/GA at birth may allow further assessment of the effect of these clinical states.  
The lack of effect of HCA on white matter integrity in this population may be further explained 
by the heterogeneity of HCA which includes a range of maternal and foetal inflammation and 
therefore may impact on the foetal inflammatory response. This may also explain data 
produced by other groups which have shown that HCA confers no adverse effect on 
neurodevelopmental outcome (Dexter SC et al, 2000; Andrews WW et al, 2008). In future 
work, it would be interesting to report the degree and site of HCA. Furthermore, as HCA is 
known to increase PVL and IVH (Shatrov JG et al, 2010), it may be interesting to include infants 
with HPI or cystic PVL as determined on cranial ultrasound provided these lesions did not 
significantly impact on the ability to perform DTI analysis.  
The use of DTI analysis technique may have contributed to the lack of effect observed by not 
only HCA but also with respect to the presence of BPD. Region-of-interest analysis was chosen 
for its high sensitivity, ease of application, and the presence of a clear hypothesis (generated 
by previous studies) which demonstrate a significant effect of prematurity on FA and MD in 
well-defined white matter regions. In addition, many clinical software packages ROI is the only 
option (Hakulinen U et al, 2012). A geometrical 1mm voxel square ROI was used to minimise 
variation between subjects and data which had significant motion artefact present was 
discarded. However, the lack of a robust neonatal atlas at the time of image analysis meant 
that my ROI placement required a manual approach. Techniques which require users to 
identify anatomical structures and manually describe regions-of-interest are subject to intra 
and inter user variability and therefore may not be suitable for cross-sectional studies 
(Froeling M et al, 2016). Furthermore, ROIs may not represent a white matter tract in its 
entirety and other voxel-based or tractography techniques may be more informative.  
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With this in mind, a recent voxel-based (TBSS) study by Anblagan et al, has shown that HCA is 
associated with decreased FA in the genu, cingulum cingulate gyri, centrum semiovale, 
inferior longitudinal fasciculi, limbs of the internal capsule, external capsule and 
cerebellum (Anblagan et al, 2016). Additionally, Ball et al demonstrated a significant 
reduction in FA within the centrum semiovale, corpus callosum and inferior longitudinal 
fasciculus in infants with BPD by using TBSS (Ball G et al, 2010), and Boardman et al showed 
that infants with prolonged respiratory  illness have small cerebral volumes as determined by 
volumetric analysis (Boardman et al, 2007). It is therefore important to evaluate which 
approach is most informative for ongoing work and a comparison of ROI and tractography 
based techniques would inform this.  
Further considerations which may have impacted results include problems with data 
collection. A difficulty I faced with acquiring the DTI data was movement artefact from 
unsettled infants, with a dropout rate of 5% of consented preterm and 27% of term infants. I 
was granted ethical approval to scan infants during natural sleep, with swaddling and ear 
protection to aid their comfort. Other studies have used sedation (Counsell SJ et al, 2008 & 
Boardman JP et al, 2010) to aid natural sleep, and this could have improved my data capture, 
particularly in the term cohort.  
In addition, our DTI protocol could be varied in future to include less DTI directions or smaller 
b-values (Dudink J et al, 2008) which would allow for a shorter scan time and therefore 
increase the amount of subjects with DTI data.  
Another challenge was the logistical organisation of consenting and scanning term infants, 
within the desired 38-42-week time period. As a result, PMA at time of scan was significantly 
higher for term infants compared to preterm infants. The DTI data were therefore corrected 
for PMA at birth as both FA and MD change rapidly during perinatal brain development (Huppi 
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PS et al, 1998). Antenatal consent of term infants may have reduced the discrepancy between 
PMA in the infant cohorts. However, despite these challenges, I was able to meet 95% of my 
target subject numbers for both preterm and term infants.  
This method of DTI analysis, used manual ROI placement and therefore may be subject to 
operator bias, despite being blinded to gestational age and clinical state. As demonstrated in 
the paper by Woodward et al, (Woodward LJ et al, 2006) there are structural changes 
associated with preterm delivery which may be identifiable on FA maps such as gyral 
maturation and size of the subarachnoid space. Therefore, other techniques, such as 
tractography, which provide an objective measure of FA and MD could be considered to 
analyse this data.  
 
3.5 Conclusions  
In conclusion, within this cohort of preterm infants at term and term controls, preterm birth 
is associated with significant alterations to white matter integrity as assessed using ROI 
analysis.  
Within the limits of this work, in our preterm population, exposure to antenatal magnesium 
sulphate, histological chorioamnionitis and the development of bronchopulmonary dysplasia 
may be associated with alterations in white matter microstructure at term equivalent age.  
This methodology which involves manual placement of ROIs may be subject to operator bias 
and therefore other techniques which are more objective (such as tractography) should be 





Chapter 4: Comparison of DTI techniques in a Neonatal Population 
4.1 Introduction  
4.1.1 Introduction  
As discussed in chapter 3, the quantitative measurements of DTI, namely FA and MD are 
predictive of neurodevelopmental outcome after preterm birth, with FA consistently 
decreased and MD increased in preterm infants at term equivalent age (Counsell et al 2006, 
Counsell et al 2008, van Kooij et al 2012, Plaisier et al 2013, Roze et al 2015).  
The corpus callosum, corticospinal tracts and posterior limbs of the internal capsule have 
been a focus of research attention as potential biomarkers because their microstructural 
properties in the neonatal period have been associated with functional outcome in childhood 
(Stewart AL et al 1999, Arzoumanian Y et al 2003, Anjari M et al 2007, Dudink J et al 2007, van 
Koij BJ et al 2012, Duerden EG et al 2015). These tracts show dynamic changes in myelination 
and organisation of white matter tracts during the 3rd trimester (Counsell et al 2002, Braga 
RM et al 2015) and are therefore susceptible to damage by preterm birth and its associated 
clinical sequelae.  
As well as the method known as region-of-interest analysis (ROI) which, I used in chapter 3, 
DTI measurements can be calculated by a voxel based approach called tractography. The 
more traditional ROI approach performs calculations on the original MRI slice which 
minimises the possibility of post processing errors. However, ROIs do not represent white 
matter tracts as a whole and results can vary according to operator as well as shape and size 




Probabilistic neighbourhood tractography was first described by Clayden et al (Clayden JD et 
al 2006, Clayden JD et al 2007) and recently has been refined for use in the neonatal brain 
(Anblagan D et al 2015). In contrast to ROI, it is an unbiased method which produces 
measurements of FA and MD as an average of the entire fibre bundle, however data can be 
affected by image artefact and other crossing neuronal tracts (Alexander AL et al 2007). If DTI 
is to be used to quantify white matter injury in preterm infants for prognostic or therapeutic 
studies, it is important to know the agreement of results obtained between various methods 






4.1.2 Hypotheses and Aims  
I hypothesised that there would be limited agreement between measurements of FA and MD 
generated by different methods of DTI analysis, namely region-of-interest and tractography 
methods. I aimed to investigate this by testing agreement between measurements of FA and 
MD within the genu of the corpus callosum and the right and left corticospinal tract 
pathways/PLIC because these are of most obvious clinical utility and can be segmented 
reliably using PNT.  
I also hypothesised that there would be good repeatability of the region-of-interest (ROI) 
technique when used by the same individual. In this study, I aimed to assess this by comparing 
repeated ROI measurements of FA and MD within the genu of corpus callosum, right and left 





4.2 Methods  
4.2.1 Demographic Data Collection  
As per methodology in 3.2.1, birthweight (kilograms), gestational age at birth (weeks) and 
infant gender were collected with consent from maternal notes. Corrected gestational age 
(weeks) at time of scan was calculated and infants were weighed (kilograms) and had their 
OFC (cm) measured.  
4.2.2 DTI Data Collection  
Infants were recruited as per methods 2.1 and underwent MRI scanning at term equivalent 
age, as described in methods 2.2 with post MRI data processing as per 2.2.4.  
4.2.3 Measuring FA and MD by Different DTI Methods  
Probabilistic neighbourhood tractography (PNT) analysis was performed for all infants with 
suitable data after processing (n= 81) using the method described in 2.2.5.2. These methods 
are visualized in Figure 4.1  
ROI data was analysed as per methods as per 2.2.5.1 from 81 tractography matched infants 







Figure 4.1 Illustration of ROI and tractography mapping  
a. Reference tract of genu of corpus callosum calculated from term controls displayed in green 
and overlaid on an age-specific standard space template b. illustration of segmentation of 
whole genu for an individual subject calculated using PNT c: ROI placement in genu of corpus 
callosum d: reference tract of right CST e. reference tract of left CST f. ROI placement in right 


















4.2.4 Repeatability of ROI Analysis  
ROI analysis was repeated for 81 infants within the genu of the corpus callosum and the right 
and left PLIC, with subsequent FA and MD documented. These measurements were 
performed independent in time (on different dates) to previous ROI analysis and with blinding 
to previous results.  
 
4.2.5 Statistical Analysis  
Data were analysed using SPSS Statistics version 21 (International Business Machines 
Corporation (IBM), USA). Data were checked for normality of distribution and homogeneity 
of variance.  
Pearson’s correlation and Bland Altman plots were used to assess agreement between DTI 
parameters calculated from ROI and PNT for each tract. Scatter plots were utilised to further 
assess correlation between the 2 methods.  
Intra-class correlation coefficient (ICC) and Bland Altman plots were used to assess intra-rater 
variability between ROI measurements.  
95% limits of agreement were calculated rather than 95% confidence intervals for Bland-
Altman as these were felt to provide more information on clinical utility of results.  





4.3 Results  
4.3.1 Patient Demographics  
Matched tractography data was available for 81 patients of the original 95 infant DTI group. 
Data from preterm and term control infants were assessed as whole group because two 
technical approaches were being compared and gestational age of the infant would not 
confound that assessment. The demographics for this patient group are presented in table 
4.1.  
Table 4.1 Patient Demographics    
  All Infants (n = 81) 
Birthweight (Kg)* 1.58 (0.55 to 4.26) 
Gestational Age at Birth (decimal weeks)* 31.28 (23.29 to 41.71) 
Gestational Age at Sample (decimal weeks)* 40.3 (37.29 to 45.43) 
Weight (Kg) at Sample* 2.99 (2.06 to 4.26) 
OFC (cm) at Sample* 34.9 (31 to 38) 
Female** 40 (49.4) 
  
* Mean (range)  






4.3.2 Repeatability of Region-Of-Interest Analysis  
 
The repeated ROI measurements of FA and MD (×10-3 mm2/s) in the genu of corpus callosum, 
right and left PLIC along with Intraclass Correlation Coefficients and Bland Altman plot values 
are shown in table 4.2.  
There was a low magnitude of difference for both FA (0.005 to 0.004) and MD (0.003 to 0.005 
×10-3 mm2/s) across the three white matter regions. Additionally, both FA and MD had 95% 
limits of agreement which included the possibility of no difference in the mean values 
between results.  
ICC levels were high for FA in all 3 tracts (above 0.85). For MD, ICC was lower than FA with 
levels above 0.77 in the genu and right CST, falling to below 0.6 in the left CST.  













Table 4.2 Intra-rater agreement of FA and MD in 3 white matter regions-of-interest (ROI) 













ROI Measure 1* 0.38 1.38 0.423 1.033 0.43 1.031 
  (-0.08) (-0.19) (-0.06) (-0.05) (-0.05) (-0.04) 
ROI Measure 2* 0.39 1.39 0.421 1.031 0.42 1.024 
  (-0.09) (-0.16) (-0.06) (-0.05) (-0.05) (-0.05) 
Mean difference -0.001 -0.005 -0.0005 0.003 0.004 0.002 
95% Limits of 
agreement  
-0.08 
 to  
0.08 
-0.30 
 to  
0.29 
0.08 
 to  
0.08 
-0.08 







0.1    
ICC  0.935 0.775 0.856 0.788 0.861 0.562 
95% CI of ICC 0.90 
 to  
0.96 
0.65 
 to  
0.86 
0.78 









 to  
0.72   
p value of ICC <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
 
Note: - *Values are Mean (SD), ROI Measure 1 was first measurement obtained by assessor, 
ROI Measure 2 was second measurement obtained by assessor. Measurements were taken 
on different days with blinding to previous value.  
95% limits of agreement - Mean difference between region of interest values ± 1.96 
standard deviation of the difference 
ICC – Intraclass correlation coefficient. <0.40—poor, 0.40 and 0.59 – fair, 0.60 and 0.74 – 
good, 0.75 and 1.00 - excellent. 





















































Figure 4.2a BA Plot: Agreement of FA values in right PLIC  
Figure 4.2c BA Plot: Agreement of FA values in gCC 





























Figure 4.3a BA Plot: Agreement of MD values in right PLIC  
Figure 4.3b BA Plot: Agreement of MD values in left PLIC  
Figure 4.3c BA Plot: Agreement of MD values in gCC  
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4.3.3 Agreement of Tract Averaged Versus Region-of-Interest Measured DTI Parameters 
 
The Mean (SD) for FA and MD (×10-3 mm2/s) generated from PNT and ROI analysis within the 
genu of corpus callosum, left and right CST (PLIC) are displayed in table 4.3 along with Pearson 
correlation analysis and Bland Altman and Scatter Plot values.   
In all three white matter regions, FA and MD showed significant correlation but poor 
agreement. 
The mean difference in FA measured using PNT or ROI ranged between 0.13 and 0.17 for the 
three tracts. 95% limits of agreement for FA values did not include the possibility of no 
difference in the mean values generated by different techniques.  
The mean difference in MD measured using PNT or ROI ranged between 0.101 and 0.184 ×10-
3 mm2/s for the three tracts. The 95% limits of agreement for MD values did include the 
possibility of no difference in the mean values within the genu of corpus callosum, when 
comparing results generated by PNT or ROI analysis.  
Pearson’s correlation in each region varied from high to low correlation, with lowest in FA of 
the genu (R = 0.24) to highest in FA of the right CST (R = 0.544).  
This is further demonstrated by the Scatter Plot analysis which demonstrates positive 
correlation between the values.   
This data are further represented by Bland Altman Plots (Figures 4.4a, b, c & 4.5a, b, c) and 




Table 4.3 Agreement of FA and MD in 3 white matter regions using PNT and ROI methods 
 
Note: - *Values are Mean (SD)  
95% limits of agreement - Average difference between tract averaged and region of interest 
values ± 1.96 standard deviation of the difference 
Pearson correlation - high correlation: 0.5 to 1.0, medium correlation: 0.3 to 0.5, low 
correlation: 0.1 to 0.3  
P value of Pearson correlation: <0.05, is statistically significant  
 
 













Bland Altman Analysis 
Tract averaged value*  0.22 1.473 0.27 1.167 0.29 1.216 
  (0.04) (0.095) (0.03) (0.066) (0.03) (0.073) 
Region of interest 
value* 
0.38 1.371 0.42 1.032 0.43 1.031 
  (0.08) (0.164) (0.06) (0.052) (0.05) (0.042) 
Mean difference -0.17 0.101 -0.15 0.136 -0.13 0.184 














  -0.32 0.415 -0.05 0.267 -0.05 0.307 
Pearson correlation Analysis  
Pearson correlation 
(R) 
0.24 0.335 0.544 0.38 0.467 0.529 
p value of Pearson 
correlation  
0.032 0.002 <0.001 <0.001 <0.001 <0.001 
Scatter Plot Analysis 
Y intercept 0.28 0.52 0.18 0.68 0.24 0.67 
Slope 0.46 0.58 0.89 0.3 0.64 0.3 
R2  0.057 0.112 0.296 0.144 0.218 0.279 
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Figure 4.4a BA Plot: Agreement of FA in right PLIC/CST (ROI 
Figure 4.4b BA Plot: Agreement of FA in left PLIC/CST (ROI 
Figure 4.4c BA Plot: Agreement of FA in gCC (ROI versus PNT)  
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Figure 4.5a BA Plot: Agreement of MD in right PLIC/CST (ROI 
Figure 4.5b BA Plot: Agreement of MD in left PLIC/CST (ROI 









4.4 Discussion  
Within this chapter, I have demonstrated that FA and MD values calculated with the corpus 
callosum (gCC) and corticospinal tract (CST) by region-of-interest (ROI) analysis show poor 
agreement with whole tract averaged values. The low level of variability found between 
repeated FA and MD values calculated by ROI analysis suggests that the variation seen 
between ROI and tract averages (PNT) techniques is not explained by operator bias.  
As discussed in chapter 3, I observed similar values in the neonatal population compared to 
other ROI studies (Counsell et al, 2006, Arzoumanian et al, 2003, Rose et al, 2009) but also 
compared to other tractography studies (Liu et al, 2012) and therefore the data from this  
subject group can be considered representative.  
Several studies have shown that relatively modest differences in FA and MD when measured 
in preterm infants at term equivalent age are associated with altered neurodevelopmental 
outcomes (Rose et al 2009, van Kooij et al, 2011, van Kooij et al 2012, Thompson et al, 2012). 
Therefore, the differences found between ROI and tract averaged DTI parameters may 
include clinically significant values.   
The differences in values generated by ROI and PNT methods may be explained by patterns 
of myelination, tract growth and organisation which are observed in DTI studies of the 
developing neonate. The myelination of white matter proceeds in a staged fashion with the 
first phase involving proliferation and maturation of oligodendrocytes near axons and a 
reduction in brain water content. The second phase sees oligodendrocyte processes 
encapsulating the axons before full myelination occurs. Changes in anisotropy precede the 
macroscopic appearance of myelin (Wimberger et al, 1995, Zanin et al, 2011, Nossin-Manor 
et al, 2013, Dubois et al, 2014). Other maturational factors which can affect DTI 
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measurements include increasing axonal diameter and compactness of white matter fibres 
(Neil et al, 1998 & McGraw et al, 2002). These factors, along with the stages of myelination 
vary between and within white matter tracts and therefore the same tract can have 
differences in FA and MD along its length (Gilmore et al, 2007).  
The corpus callosum undergoes linear volumetric growth during the third trimester, with 
dynamic increases in growth continuing in early childhood (Nishida et al, 2006 & Tanaka-
Arakawa et al, 2015). Myelination of the corpus callosum proceeds caudo-cranially, and only 
reaches the genu (gCC) by 6 months’ post term (Deoni et al, 2011). Therefore, the higher FA 
and lower MD values found with ROI analysis compared to PNT in the gCC must be explained 
by the maturational factors that precede myelination, such as axonal growth and reduced 
water content.  
The corticospinal tract (CST) is partially myelinated by term equivalent age, with the posterior 
limb of the internal capsule showing increased signal on T1 weighted images by 38-40 weeks’ 
gestation (Counsell et al, 2002, Gilles et al, 2012). However, myelination within the CST 
continues throughout the first 2 years of life with increases in FA and reductions in MD evident 
in sequential imaging studies (Mukherjee et al, 2001, Provenzale et al, 2007). The higher FA 
and lower MD values observed from ROI data in the PLIC compared to PNT in the CST can 
therefore be explained by differences in myelination across the tract.  
The poor agreement of measurements observed demonstrates that DTI parameters produced 
by ROI methods do not represent the microstructural characteristics of a functional tract in 
its entirety. Therefore, when considering an ROI approach, it must be considered that the site 
of measurement within a particular tract can heavily influence the reliability of results.  
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In line with other ROI reliability studies, the intra-observer agreement of FA and MD values 
produced by manual ROI placement in the gCC and PLIC was high (Lepomaki et al, 2012). 
However, inter-observer precision is shown to be approximately 1/3rd of intra-observer 
(Muller et al, 2006 & Ciccarelli et al, 2003). These differences can be explained by the 
subjective nature of ROI analysis. It is reliant on slice choice and manual ROI placement, size 
and shape. Angulation between slices and the partial placement of ROIs in areas of CSF or 
grey matter may significantly alter FA and MD values (Bonekamp et al, 2007). Therefore, 
region-of-interest analysis requires an operator with experience in neonatal neuroanatomy 
and a consistent accurate placement of the ROI within specific white matter tracts before the 
resulting DTI parameters can be considered valid as biomarkers.  
Further work with regards to understanding the variation between ROI and PNT methods 
could include the analysis of other white matter tracts/region of interest such as the anterior 
limb of the internal capsule and splenium of the corpus callosum. Additional imaging 
protocols such as myelin water fraction, a quantifiable measurement of T1 and T2 relaxation 
which is specific to myelin (Deoni et al, 2011 & Deoni et al, 2012) may also be informative in 
explaining the within tract variations I have observed.  The reliability of ROI analysis was 
explored within this chapter, however the reliability of PNT was not, and future work to 
examine this would be of interest. In addition, it would be interesting to re-analyse the data 
within chapter 3 using the tractography approach, as this may provide results which are more 
representative of the effect of clinical parameters on white matter tracts.  
4.5 Conclusions  
In conclusion, FA and MD values obtained by ROI and tract-averaged approaches show limited 
agreement. ROI methodology is subjective and may not be representative of the 
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microstructural integrity of an entire white matter tract. Variability between measurements 
is an important factor to consider when using the ROI approach in cross-sectional and 
longitudinal studies, and a more objective method such as PNT may be preferable. ROI 
methods should be used with caution according to a rigid processing protocol and in the 
knowledge that they provide limited representation of the whole tract.   
On the basis of these conclusions, the results obtained from PNT analysis will be used as the 




Chapter 5: The Epigenetics of Preterm Birth - From Methylome to 
Phenotype 
5.1 Introduction  
5.1.1 Introduction  
The perinatal environment that the preterm infant experiences is both physically stressful; 
with exposure to bright lights, high noise levels and noxious stimuli (Als H et al, 2004) and 
physiologically stressful due to hemodynamic instability and variable oxygen levels, 
temperature change, altered nutrition and susceptibility to infection. Early life stress confers 
risk of later life metabolic and neuropsychiatric disease (Huang C et al 2010, Susser E et al 
1992, St Clair D et al 2005) and these effects are transmissible through subsequent 
generations (Drake AJ et al, 2004 and Drake AJ et al, 2005).  
DNA methylation is a stable form of epigenetic regulation which is heritable, at least through 
meiosis (Moore LD et al, 2013). There is evidence from both animal and human studies that 
DNA methylation is altered in association with early life stress (Weaver IC et al 2004, Mueller 
BR et al 2008, Roth TL et al 2009, Labonte B et al 2012, McGowan PO et al 2009, Tyrka AR et 
al 2012). DNA methylation is essential for normal neuronal development (Hutnick LK et al, 
2009), myelination (Moyon S et al, 2016) and has a role in learning, memory and social 
cognition (Feng J et al 2010, Zhao X et al 2003, Allan AM et al 2008). In addition, disruption of 
normal DNA methylation patterns are implicated in neurodevelopmental and 
neuropsychiatric diseases including Rett Syndrome (Graff J et al, 2011), depression (Khulan B 
et al, 2014, Tyrka AR et al, 2016), bipolar disorder (Fries GR et al, 2016), schizophrenia 
(Abdolmaleky HM et al, 2006) and behavioural disorders such as autism (Loke YJ et al, 2015).  
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Preterm infants have an increased risk of developing autistic spectrum disorder (Johnson S et 
al, 2010a), attention deficit (Sucksdorff M et al, 2015) and depression or psychosis (Nosarti C 
et al, 2012) and there are studies showing altered DNA methylation in preterm infants 
(Bromer C et al, 2013, Paquette AG et al, 2013 & Paquette AG et al 2014, Cruickshank MN et 
al, 2013) which suggests a possible mechanism linking preterm birth, DNAm and 
neurodevelopmental disorders. In living human studies such as the preterm population, a 
surrogate tissue is required for neuroepigenetic investigation and DNAm from saliva has 
shown good correlation with patterns of DNAm in post-mortem brain tissue (Nohesara S et al 
2011 and Ghadirivasfi M et al 2011). Therefore, it is possible to study the effect of prematurity 
on DNA methylation by non-invasive saliva sampling. Quantitative measurements generated 
by DTI can serve as a biomarker of preterm white matter injury and are predictive of 
neurodevelopmental outcome. Therefore, the relationship between DNAm and structural 
brain development can be investigated by diffusion MRI and evaluation of the methylome in 
preterm subjects.  
5.1.2 Hypotheses and aims  
I hypothesised that the stress of preterm birth will lead to alterations in the methylome that 
are apparent early in the newborn period. In particular, I hypothesised that there will be a 
significant alteration in DNAm at gene loci which are associated with neurological function 
and/or neurological disease.  
I aimed to investigate this by collecting DNA from accessible tissue (saliva) from a sex-
matched population of preterm infants at term corrected gestation and term control infants 
and performing a genome wide methylation array.  
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I also hypothesised that variance in DNAm is associated with DTI parameters in major white 
matter tracts and clinical risk factors for adverse outcome. 
Chapter 4 concluded that PNT may provide more information about white matter integrity at 
the level of neural systems and therefore, I aimed to use whole tract-averaged data from 8 





5.2 Methods  
5.2.1 Pilot Study  
To assess feasibility, an initial pilot study was conducted using 5 term control infants and 7 
preterm at term corrected age. The methodology for the collection of DNA, extraction, 
quantification, DNA methylation array and Bioinformatics processing were identical to those 
described below.  
5.2.2 Patient Recruitment and Selection  
I collected DNA from 72 infants (36 preterm and 36 term sex-matched controls) with DTI 
image linked data available for the entire preterm cohort. Inclusion and exclusion criteria and 
recruitment methods are outlined in 2.1.  
5.2.3 Demographic Data Collection  
As outlined in 3.2.1, with maternal consent, maternity notes were interrogated for maternal 
and perinatal demographics. With parental consent, infant notes were interrogated for 
relevant neonatal demographics. At time of sampling, infants were weighed (kilograms), 
corrected gestational age (PMA) calculated and exposure to breast milk was determined.  
5.2.4 DNA Collection and Extraction  
As described in 2.3 DNA was obtained by use of saliva collection swabs, anonymised with a 
study code and stored within a secure laboratory until time of analysis.  
DNA was extracted from the samples, quantified and qualified as per methods 2.4.1 to 2.4.3 
with a mean (range) DNA yield of 45.9 ng μl− 1 (13.4 – 95.9) from preterm infant saliva samples 
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and 36.35 ng μl− 1 (8.12 – 80) from term infant saliva samples. The extracted DNA was labelled 
with the appropriate anonymised study code and stored at 4ºC.  
5.2.5 DNA Methylation Array 
500 nanograms of DNA for 36 preterm and 36 term control subjects was passed to the 
Edinburgh Clinical Research Facility, for completion of a DNA methylation array using the 
Illumina HumanMethylation 450 Beadchip as described in 2.5.1 and provided results across 
approximately 485,000 probes.  
The raw data is available to view at NCBI's Gene Expression Omnibus and is accessible 
through GEO Series accession number GSE72120 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc =GSE72120). 
Raw data was then processed as per 2.5.2 with 112,818 probes were subsequently removed 
in steps that included: 
Pre-filtering 
1. Probes on SNPs (n = 66,877) 
2. Non-specific probes (n = 26,505) 
3. Sites with excess high detection P-values (n = 8,852) 
Post-filtering  
1. Non-CpG probes (n = 1130) 






5.2.6 Assessment of Genes with Neurological Interest and Array Validation  
I conducted a literature review of the protein coding genes which showed significantly 
differentially methylated regions between preterm and term infants. This allowed 
identification of genes which had evidence of involvement in neurological processes or the 
pathophysiology of neurological disease. This informed the choice of candidate genes used 
for pyrosequencing validation using methods described in 2.6.  
5.2.6.a Literature review  
The steps involved in this literature review were:  
1. Identify from DNA methylation array, genes which are classified as protein coding  
2. Gene codes were entered in to the National Center for Biotechnology Information  
3. Gene codes aliases were tabulated i.e. SLC7a5 aka LAT1 
4. A PubMed enquiry using the following search criteria was used for each gene alias, i.e. 
PubMed (GeneRIF) Links for Gene (Search slc7a5[gene] AND alive[prop] NOT 
newentry[gene]) 
5. Articles were interrogated for relevance to a defined human neurological disease or 
evidence for involvement in neural processes. If present, genes were classified as 
‘neural genes’  
6. Information in relation to other genes was also collected and summarised  
5.2.6.b Pyrosequencing  
After bisulphite conversion, pyrosequencing PCR primers were optimised using a temperature 
gradient. The optimal annealing temperatures for each PCR product is displayed in table 5.1 
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with an illustration of the gel electrophoresis plate after temperature optimisation shown in 
figure 5.1.  
Table 5.1 Optimal annealing temperature for pyrosequencing primers (°C) 
 Optimal Annealing Temperature (°C) 
Gene 
symbol 
F and R 
Primer 
Biotin 
Primer Sequencing Primer 
SLC7a5 56.2 57.1 56.3 
SLC1a2 55.7 57.1 56.3 
NPBWR1 55.4 57.1 57.1 
APOL1 55.4 57.1 57.1 
QPRT 56.7 55.6 57.1 
 
Figure 5.1 Qualification of optimal annealing temperature for F and R primers with gel 
electrophoresis  
Image shows 100bp DNA Ladder in position 1 with subsequent positions displaying forward 
and reverse primers specific to a particular gene of interest with PCR amplification along a 























5.2.7 Quantification of White Matter Integrity  
The preterm infants (n=36) had DTI parameters calculated by PNT analysis in eight major 
white matter fasciculi (genu and splenium of corpus callosum, left and right cingulum 
cingulate gyrus, left and right corticospinal tracts (CST), and left and right inferior longitudinal 
fasciculi) as per methods 2.2.5.2. In addition to the average FA and MD calculated for each 
tract of interest, a measurement of the absolute goodness-of fit of the segmented tract to 
the reference (R) was produced to quantify differences in tract shape between individual 
subjects.  
5.2.8. Statistical Analysis  
5.2.8.1 Bioinformatics  
As described in methods, 2.5.2 Differential methylation between the preterm and term 
infants was assessed using Limma in i) gene promotors (1.5 kb upstream to 0.5 kb 
downstream of the transcription start site) and ii) gene bodies. A generalisation of Fisher’s 
method with FDR correction (p value <0.05) generated genes with significantly differentially 
methylated regions (DMR) (Smyth GK, 2005). 
5.2.8.2 Pyrosequencing  
Pyrosequencing uses bisulphite treatment, which deaminates unmethylated cytosines to 
uracil, whilst methylated cytosines remain unaffected, to give a read out of % DNA 
methylation at individual CpGs within a population of cells. Mean methylation was compared 
using independent t-tests. 
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5.2.8.3 Demographics  
Data were analysed using SPSS Statistics version 21 (International Business Machines 
Corporation (IBM), USA). Data were checked for normality of distribution and homogeneity 
of variance. Independent t-tests were used for continuous data and CHI squared analysis for 
categorical data.  
5.2.8.4 Principle Components Analysis  
Dimension reduction was performed using principal components analysis to assess which 
clinical variables and imaging features were related to signal in the methylation values within 
the preterm group. The clinical variables tested were: gender, PMA at birth, PMA at scan, 
chorioamnionitis, exposure to antenatal steroids, exposure to antenatal magnesium sulphate, 
number of days requiring parenteral nutrition and one/more episodes of late-onset sepsis. 
The image features tested were tract-averaged FA, tract-averaged MD, and R for the eight 
major fasciculi. 
These clinical and image features along with co-ordinates of the principle components space 
were tested for association. For categorical data association, a 2-sided Fisher’s exact test was 
used, for numerical data the correlation coefficient was calculated, and a p value estimated 
using permutation testing with 10,000 permutations. For comparison of numerical (A) and 
categorical data (B) associations then the p value was calculated by comparing the numerical 
values (A) in each category of (B), using a two-sided Wilcoxon rank sum test for 2 categories 
in (B) or a Kruskal-Wallis one-way analysis of variance if there were more than 2 categories. 
Due to the high number of variables, p-values were corrected using FDR and a p value of <0.05 
was considered significant. 
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5.3 Results  
5.3.1 Patient Demographics  
Patient demographics in relation to epigenetic analysis are displayed in table 5.2.  
Table 5.2 Patient demographics for infants selected for DNA methylation array  
 
  Term Infants n=36 Preterm Infants n = 36 P value 
Birthweight (Kg)* 3.57 (2.64 to 4.68) 1.047 (0.568 to 1.46)  
Gestational Age at Birth* 40 (38.14 to 42.0) 28.38 (23.29 to 32.71)  
Gestational Age at Sample* 41.24 (38.43 to 47.14) 39.76 (38.0 to 42.57) 0.001 
Weight (Kg) at Sample* 3.717 (2.64 to 4.83) 2.83 (2.06 to 3.57) <0.001 
Female** 18 (50) 18 (50)  
Maternal Age * 34 (19 to 45) 31 (17 to 42) 0.071 
Maternal BMI* 24.7 (19 to 36.4) 24.7 (18 to 37.6) 0.996 
Preconception Folic Acid** 22 (61.1) 14 (38.9) 0.059 
Diabetes (Gestational or IDDM)** 0 (0) 3 (8.3) 0.077 
Multiple Birth** 0 (0) 17 (47.2) <0.001 
IUGR** 0 (0) 4 (11.1) 0.04 
ART** 1 (2.8) 7 (19.4) 0.024 
Chorioamnionitis** n/a 11 (30.6) n/a 
Exposure to Antenatal Steroids** 0 (0) 35 (97.2) n/a 
Exposure to Magnesium Sulphate** 0 (0) 20 (55.6) n/a 
Vaginal Delivery** 12 (33.3) 11 (30.6) 0.465 
BPD ** 0 (0) 14 (38.9) n/a 
NEC** 0 (0) 2 (5.6) n/a 
Late onset sepsis**  0 (0) 10 (27.8) n/a 
Breast Milk** 31 (86.1) 23 (63.9) 0.029 
TPN duration (days)*  0 (0) 11 (5-25) n/a 
Ethnicity: White British 34 (94.4) 31 (86.1) n/a 
Ethnicity: White Other 2 (5.6)  4 (11.1) n/a 
Ethnicity: African 0 (0) 1 (2.8) n/a 
Ethnicity: Asian 0 (0) 0 (0) n/a 
* Mean (range)  
** Number (percentage) 
  
ART = Artificial Reproductive Therapy  
IUGR = Birthweight below the 3rd centile for gestation   
BPD = Bronchopulmonary Dysplasia defined as an oxygen requirement at 36 weeks corrected gestation  
NEC = Necrotising Enterocolitis, Bell Stage II or above  
Late Onset Sepsis = Clinical instability requiring antibiotics with a positive blood culture  





5.3.2 Methylation Array   
There was significantly different methylation between term controls and preterm infants at 
term corrected age, within 87 gene bodies, of which 25 were classified as protein coding 
genes.  
There was significantly different methylation within 138 promoter regions, of which 58 are 
known to be protein coding genes.  
There were 34 genes which showed differential methylation in both gene body and promoter 
regions and of these, 11 were protein coding genes.  
The data are available in supplementary tables 1 and 2 within the appendix.  
 
5.3.3 Identification of Genes with Associated Neural Function/Neurodevelopment or 
Involvement in Neurological Pathology   
I identified 10 protein coding genes which showed differential methylation between preterm 
infants at term and term controls and had good evidence for involvement in neural processes 
and/or neurological disease. These genes are summarised in tables 5.3a and 5.3b. The 
differential methylation patterns are displayed in figure 5.2.  
The function of the other genes identified as significantly different by the methylation array 





Table 5.3a Differential methylation between preterm infants at term equivalent age and term control infants in protein-coding genes with 






Differentially Expressed Genes       












P FDR  
  
Direction of change in 
 preterm infants compared to 
term  
SLC7a5 26 0.61 0.56 0.0019 Reduced 
APOL1  1 0.086 0.061 0.052 Reduced 
LRG1 2 0.69 0.62 0.018 Reduced 
Differentially Expressed Promotors       












P FDR  
  
Direction of change in 
 preterm infants compared to 
term  
SLC7a5 1 0.75 0.71 0.0053 Reduced 
SLC1a2 4 0.19 0.17 0.0014 Reduced 
NPBWR1 1 0.67 0.58 0.0084 Reduced 
QPRT  1 0.14 0.18 0.00067 Increased 
LRG1 2 0.58 0.48 0.00076 Reduced 
PRPH 1 0.21 0.27 0.00034 Increased 
GRIK5 1 0.18 0.22 0.0096 Increased 
TREM2 1 0.76 0.73 0.029 Reduced 









Gene Symbol  Gene Name Summary of Gene Function 
SLC7a5 
Solute carrier family 7 (amino acid transporter 
light chain, L system), member 5 Large amino acid transporter across the blood brain barrier 
 
SLC1a2 
Solute carrier family 1 (glial high affinity 
glutamate transporter), member 2 Clears excitotoxic neurotransmitter glutamate from extracellular space 
QPRT  Quinolinate phosphoribosyltransferase 
 
Catabolises quinolinate, an excitotoxic neurotransmitter  
GRIK5 Glutamate receptor, ionotropic, kainate 5 
 
Receptor to the excitotoxic neurotransmitter glutamate  
APOL1  Apolipoprotein L, 1 
 
Upregulated brains of schizophrenics, promotes autophagic cell death  
LRG1 Leucine-rich alpha-2-glycoprotein 1 
 
Increased in Alzheimer's disease & Parkinson's, may activate brain microglia  
TREM2 Triggering receptor expressed on myeloid cells 2 
 




Involved in neurite stability and development  
NPBWR1 Neuropeptides B/W receptor 1 
 




Melanin-concentrating hormone receptor 1 
 
 





Table 5.4a Differential methylation between preterm infants at TEA and term controls in protein coding gene bodies (other genes) 
Gene Body Product  Summary of Biological Function Literature 
RTP4 chemosensory transporter 4 
Golgi chaperone, regulates membrane targeting and functional activity of Mu 
opioid receptors  Decaillot FM et al, 2008 
BAAT 
bile acid CoA: amino acid N-
acyltransferase Mediates bile acid amidation, defects cause intrahepatic cholestasis  Hadžić N et al, 2012 
ACKR42 atypical chemokine receptor 4 
Overexpression leads to inhibition of cancer cell proliferation, low expression 
- poor survival in breast cancer Feng LY et al, 2009 
XAF12 XIAP associated factor 1 
Inhibits tumour cell growth, increased methylation associated with 
oesophageal cancers Chen XY et al, 2012 
C5orf63 
chromosome 5 open reading 
frame 63 No data found on biological function  n/a 
TXNDC8 thioredoxin domain containing 8 Protein specific to spermatids and associated with golgi apparatus  Jiménez A et al, 2004 
PF4V12 platelet factor 4 variant 1 Angiostasis and anti-tumour effects in breast cancer and lymphatic cells 
Van Raemdonck K et al, 
2014 
IFI351 interferon-induced protein 35 
Negatively regulates the antiviral interferon response to Vesicular stomatitis 
virus  Das A et al, 2014  
AZU11 azurocidin 1  Preprotoprotein which is proteolytically processed to a neutrophil lysosomal 
antimicrobial protein, multifunctional inflammatory mediator, upregulated  
in AD in pyramidal tracts, alterations associated with PPROM and ARDS 
Kasus-Jacobi A et al, 2014 
Dhaifalah I et al, 2013  
    
Brock AJ et al, 2015  
Lin Q et al, 2013 
TRIM16L tripartite motif containing 16-like Belongs to B-box zinc finger protein family, upregulated by oestrogen  
 
Liu et al, 1998 
MSANTD3 
Myb/SANT like DNA binding 
domain 3 No data found on biological function  n/a 





Gene Body Product Summary of Biological Function Literature 
SLAMF91 SLAM family member 9 
Part of immunoglobulin subfamily, haematopoietic cell receptor - signal 
transduction of immune functions Calpe S et al, 2008 
GPR21 G protein linked receptor 21  
Activates Gq signal pathway which mobilises calcium in response to 
extracellular stress  Bresnick JN et al, 2003 
NXPH4 neurexophilin 4 
Neuronal glycoprotein, may signal via alpha neurexin but limited data in 
literature  Missler M et al, 1998 
CDKN2B2 
cyclin-dependent kinase inhibitor 
2B 
Cell growth regulator, controls cell cycle G1 progression associated with 
melanoma and leukaemia  
McNeal AS et al, 2015  
Mai H et al 2016 
ZC3H12A1 
zinc finger CCCH-type containing 
12A 
Bifunctional enzyme, endoribonuclease and deubiquitinase activity. Involved 
in immune homeostasis, adipogenesis, angiogenesis and cardiomyocyte 
death  
Zhou L et al, 2006 
      
TMEM190 transmembrane protein 190 No data found on biological function  n/a 
KRT32 keratin 32 type 1 Acidic protein which is essential for hair and nail growth  Langbein L et al 1999 
PINLYP 
phospholipase A2 inhibitor and 
LY6/PLAUR domain containing  No data found on biological function  n/a 
C1orf65 
chromosome 1 open reading 
frame 65 No data found on biological function  n/a 
KRT76 keratin 76, type II Produces keratin 76, essential for maintenance of skin 'tight junctions' 
absence causes inflammation,  skin flaking, impaired wound healing and 
death < 3months age 
DiTommaso T et al, 2014 
      
C10orf62 
chromosome 10 open reading 
frame 62 No data found on biological function  n/a 
 
1Evidence for involvement in immune function  




Table 5.4b Differential methylation between preterm infants at TEA and term controls in protein coding gene promoters (other genes) 
Promoter 
Gene Product Summary of Biological Function Literature  
C5orf63 chromosome 5 open reading frame 63 No data found on biological function  n/a 
RTP4 (chemosensory) transporter protein 4 
Golgi chaperone, regulates membrane targeting and functional 
activity of Mu opioid receptors  Decaillot FM et al, 2008 
SERPINA11 
serpin peptidase inhibitor, clade A 
member 11 Extracellular serine protease inhibitor  Janciauskiene S, 2001 
C15orf39 
chromosome 15 open reading frame 
39 No data found on biological function  n/a 
KRT32 keratin 32 Acidic protein which is essential for hair and nail growth  Langbein L et al 1999 
CYP3A4 
cytochrome P450, family 3, subfamily 
A, polypeptide 4 
Found in liver and small intestine, important role in drug 
metabolism Thummel KE et al 1998 
LIPN lipase family N  
Expressed in granular reticulocytes of epidermis, role in 
differentiation of keratinocytes Toulza E et al, 2007 
FAP2 fibroblast activation protein alpha 
Membrane-bound serine protease, expression associated with 
carcinogenesis  
Huber MA et al, 2003 & 
Liu F et al, 2015 
INHBA inhibin beta A  
Forms subunit necessary for Inhibin and Activin, which have 
opposing effects on follicle stimulating hormone 
de Kretser DM et al, 
2002 
FAM189A2 
family with sequence similarity 189, 
member A2 No data found on biological function  n/a 
TM4SF4 
transmembrane 4 L six family member 
4 Cell surface glycoprotein that regulates cell proliferation  Wice BM et al, 1995 
CXCL101, 2 chemokine (C-X-C motif) ligand 10 
Chemokine - chemoattraction for T cells, inhibits angiogenesis and 
antitumour properties  
Angiolillo AL et al, 1995 
& Dufour JH et al, 2002  
TXNDC8 thioredoxin domain containing 8 Protein specific to spermatids and associated with golgi apparatus  Jiménez A et al, 2004 
GZMA1 granzyme A 
Serine protease from NK cells cytotoxic granules, activates 
programmed cell death. Important in infection  Lieberman J, 2010 
GPR116 G protein-coupled receptor 116 Regulates alveolar surfactant secretion  Bridges JP et al, 2013 
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S100a7a2 S100 calcium binding protein A7A Shows enhanced expression in epithelial cell cancer and psoriasis  Wolf R, 2011 
Promoter 
Gene Product Summary of Biological Function Literature  
PF4V12 platelet factor 4 variant 1 Angiostasis and anti-tumour effects in melanoma, lymphatic cells 
Van Raemdonck K et al 
2014 
GEMIN4 
gem (nuclear organelle) associated 
protein 4 
Involved in snRNP assembly and nuclear/cytoplasmic 
transportation  Lorson MA et al, 2008 
NXF1 nuclear RNA export factor 1 Implicated in export of mRNA from nucleus  Herald A et al, 2000 
SMAD31,2 SMAD family member 3 
Signal transducer, mediates TGF-beta signalling and has a role in 
regulation of carcinogenesis  Daly AC et al, 2010 
GPR21 G protein linked receptor 21  
Activates Gq signal pathway which mobilises calcium in response 
to extracellular stress  Bresnick JN et al, 2003 
RPL222 ribosomal protein L22 
Protein which forms part of the ribosomal 60s unit, mutations 
associated with endometrial cancer  Novetsky AP et al, 2013 
C16orf96 
chromosome 16 open reading frame 
96 No data found on biological function  n/a 
LYN 
LYN proto-oncogene, Src family 
tyrosine kinase 
Extensively expressed on haematopoietic cells, involved in 
phosphatase dependent inhibitory signalling Harder KW et al, 2001 
ASB5 
ankyrin repeat and SOCS box 
containing 5 May be involved in pathway protein ubiquitination  Andresen CA et al, 2014 
IFNK1 interferon, kappa Expressed in keratinocytes, confers cellular antiviral immunity  LaFleur DW et al, 2001  
ARHGEF392 
Rho guanine nucleotide exchange 
factor 39 Upregulated in hepatocellular carcinoma  Wang H et al, 2012 
ZDHHC11B zinc finger, DHHC-type containing 11B No data found on biological function  n/a 
GSDMB2 gasdermin B May be linked to hepatic and gastric secretory tumours  
Carl-McGrath S et al, 
2008 
KPRP keratinocyte proline-rich protein  Potential role in keratinocyte differentiation  Lee WH et al, 2005 
PARP10 
poly (ADP-ribose) polymerase family, 
member 10 
Regulates gene transcription by altering chromatin structure, role 





interferon-induced protein 35 
 
Negatively regulates the antiviral interferon response to Vesicular 
stomatitis virus  
 








zinc finger and BTB domain containing 
47 
 
Role in regulation of gene expression 
 
 
Kumar R et al, 2010 
 
 
CD681 CD68 molecule 
Glycoprotein expressed by monocytes and macrophages, role in 
cell adhesion and antigen presentation and atherosclerosis 
Ramprasad MP et al, 
1996 & Kurushima H et 
al, 2000 
NEIL1 nei endonuclease VIII-like 1 
Involved in DNA repair pathway, primarily removal of oxidised 
pyrimidines  Odell ID et al, 2010 
TFAP2E2 transcription factor AP-2 epsilon 
Highly expressed in skin, DNA binding protein, may have role in 
cartilage development. Association with colorectal cancer  
Niebler S et al, 2013 & 
Zhang ZM et al, 2014 
GSG1 germ cell associated 1 No data found on biological function  n/a 
PGLYRP31 peptidoglycan recognition protein 3 
Important role in innate immunity, recognises peptidoglycan - 
component of bacterial cell wall  Dziarski R et al, 2010 
GLYCTK glycerate kinase 
Underactivity of this enzyme causes D-glyceric aciduria variable 
phenotype - normal development to encephalopathy Sass JO et al, 2010 
HRASLS22 HRAS-like suppressor 2 
Involved in cellular growth and differentiation, suppression of 
growth of cancer cells in vitro  Shyu RY et al, 2008 
NAGS N-acetylglutamate synthase 
Catabolises NAG which activates CSPI, producing urea from 
ammonia. Deficiency leads to hyperammonemia  Morizono H et al, 2004 
TNFRSF13C1 
tumour necrosis factor receptor 
superfamily, member 13C 
Regulation of peripheral B cell populations, overexpression may 
lead to autoimmune disease  Mackay F et al, 2009 
PHLDB2 
pleckstrin homology-like domain, 
family B member 2 
Regulates cellular microtubule cytoskeleton and involved in 
delivery of AChR vesicles to NMJ  
Lansbergen G et al, 
2006 & Basu S et al, 
2015 
LY6G6D1 
lymphocyte antigen 6 complex, locus 
G6D Part of the major histocompatibility complex  Mallya M et al, 2002 
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DUSP13 dual specificity phosphatase 13 
Tyrosine phosphatase enzyme role in spermatogenesis and skeletal 
muscle development  Katagiri C et al, 2011 
LY6G6E1 
 
lymphocyte antigen 6 complex, locus 
G6E 
Part of the major histocompatibility complex  
 Mallya M et al, 2002 
Promoter 
Gene Product Summary of Biological Function Literature  
C5orf45 chromosome 5 open reading frame 45 No data found on biological function  n/a 
CCL201 chemokine (C-C motif) ligand 20 
Chemokine - chemoattraction for memory T cells and dendritic 
cells, inducible by LPS  Schutyser E et al, 2000 
CTB-
50L17.14 uncharacterised protein  n/a n/a 
Xxbac-
BPG32J3.20 uncharacterised protein  n/a n/a 
RP11-20I23.1 uncharacterised protein  n/a n/a 
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Figure 5.2 Differential Methylation between preterm infants at TEA and term controls at CpG sites 
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5.3.4 DNA Methylation Array Validation with Pyrosequencing  
In addition to the annotated sites from the array, pyrosequencing assays covered additional 
neighbouring CpGs in SLC7a5 (3 additional upstream), APOL1 (1 additional downstream), 
SLC7a2 (1 additional downstream) and NPBWR1 (1 additional upstream and 1 additional 
downstream). All five genes showed significantly different methylation patterns on 
pyrosequencing at all CpG sites interrogated between preterm infants at term corrected age 
and term control infants. These methylation differences were of the same direction as the 




Table 5.5 Pyrosequencing results for 5 genes (13 CpG sites) selected for validation  









SLC7a5 cg05834639 36.6 (7.2)  28.6 (8.6)  8.1 8.74E − 04 
  minus 45  77.2 (7.4) 68.9 (8.8)  8.3  8.30E − 04 
  minus 39 60.1 (8.2) 50.7 (8.9) 9.4 3.81E − 04 
  minus 23   80.0 (5.9) 71.0 (10.9) 9.1 7.68E − 04 
SLC1a2 cg25963980 31.2 (4.9)  25.7 (4.65)  5.5 5.94E − 06 
  plus 10 41.2 (5.0)  34.4 (6.0)  6.8 2.43E − 06 
NPBWR1 cg07629017 6.0 (2.8) 4.74 (1.3)  1.26 0.0195 
  minus 5  64.5 (7.5)  56.5 (10.3)  8 4.11E − 04 
  cg26205771 55.6 (7.1)  48.1 (8.1)  7.5 1.00E − 04 
  plus 4 58.4 (8.6)  50.0 (10.4)  8.4 4.57E − 04 
APOL1  cg36649144 29.5 (6.8)  24.3 (11.9) 5.2 0.0396 
  plus 9  14.6 (3.6)  11.5 (5.8) 3.14 0.0159 





Figure 5.3 Pyrosequencing validation of selected neural genes: percentage methylation in 
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5.3.5 Diffusion MRI Analysis  
DTI data were available for the entire preterm group (n=36). Figure 5.4 shows an illustration 
of the segmented white matter tracts for a representative subject. Table 5.6 shows 
descriptive statistics for FA, MD and R for the 8 eight major fasciculi identified from the DTI 
data in the preterm group using PNT.  





Top row: genu (left) and splenium (right) of corpus callosum. Bottom row (right to left): left 
CCG, right CST and right ILF. CCG = cingulum cingulate gyrus; CST =corticospinal tract; ILF = 







Table 5.6 Mean DTI parameters for 8 major white matter fasciculi in the preterm cohort 
(n=36)  
 
Mean (s.d) of tract-averaged FA and MD, and median (IQR/2) values of R for each major 
fasciculus 
  




















































































         
Abbreviations: CCG, cingulum cingulate gyrus; CST, corticospinal tract;  
FA, fractional anisotropy; ILF, inferior longitudinal fasciculus; IQR, interquartile range 
 
5.3.6 From Methylome to Phenotype: Principle Component Analysis  
95% of the variance in methylation within the preterm group was explained by 23 
components. The most variance was explained by the first two principle components (31.8% 
and 20.1% respectively). These results are shown in table 5.7 with the corresponding heat 
map for association of the first 8 principle components being shown in figure 5.5.  
In further exploratory analysis, gender was associated with the 1st principle component (PC) 
(variance 31.8%, p = 0.0071); FA in the genu of the corpus callosum was associated with the 
5th PC (3.3% variance, p = 0.0061); R of the right corticospinal tract was associated with the 
6th PC (2.9% variance, p = 0.0011) as was the presence of chorioamnionitis (2.9% variance, p 
= 0.0053). Both gender and duration of TPN were associated with the 7th PC (2.6% variance, 
p = 0.0016 and p = 0.0017 respectively).  
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After correction for multiple tests, there were three remaining associations. These were: R of 
the right corticospinal tract with the 6th PC (p =0.036); gender with the 7th PC (p = 0.028) and 
duration of TPN with the 7th PC (p =0.028).  
No variable was significantly associated with any differentially methylated region when tested 
directly (adjusted p value = 0.05).  
 
Table 5.7 Variance in differential methylation in the preterm cohort is explained by 23 
principle components  





1 31.8 31.8 
2 20.1 51.9 
3 4.5 56.4 
4 3.8 60.2 
5 3.3 63.5 
6 2.9 66.4 
7 2.6 69 
8 2.3 71.3 
9 22 73.5 
10 2.2 75.7 
11 2 77.7 
12 1.9 79.6 
13 1.8 81.4 
14 1.7 83.1 
15 1.6 84.7 
16 1.6 86.3 
17 1.6 87.9 
18 1.5 89.4 
19 1.3 90.7 
20 1.3 92 
21 1.2 93.2 
22 1.1 94.3 










5.4 Discussion  
Within this sample population of infants at term corrected gestation, preterm birth is 
associated with significant alteration of the methylome in 25 protein-coding genes and 58 
protein-coding promoters. There are significantly different patterns of methylation in the 
regions of 10 protein-coding genes which have evidence of involvement in neural cell function 
and neurological disease. In addition, there are 15 protein-coding genes with an identified 
role in immune function and 13 protein-coding genes with oncogenic associations.  
By using PCA analysis, I have demonstrated that the differential methylation seen in this 
preterm population is explained in part by clinical risk factors including: gender, exposure to 
chorioamnionitis and early nutrition i.e. the number of days of TPN required.  Furthermore, 
the PCA analysis revealed that DNA methylation is associated with white matter integrity in 
the genu of corpus callosum and corticospinal tract, demonstrating a possible link between 
the methylome and preterm neurological phenotype.  
Epigenome wide case control studies in schizophrenia (Aberg KA et al, 2014), autism (Ladd-
Acosta C et al, 2014), victims of child abuse (Labonte B et al, 2012) and depression (Khulan B 
et al, 2014), and a recent ADHD cohort study (Walton E et al, 2016) have demonstrated 
differences in DNAm at genes important in neural function. However, few studies have 
investigated the effect of prematurity on DNAm using an EWAS approach. Other groups have 
shown a correlation between gestational age at birth and DNAm variation (Lee H et al, 2012 
& Cruickshank MN et al, 2013) which may persist in to adulthood (Cruickshank MN et al, 
2013). However, this study is the first to examine the variation in DNAm between preterm 
infants at term corrected age and term controls.  
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In accordance with Cruickshank et al, I found variation in DNAm between preterm and term 
infants in the neural genes PRPH and APOL1, the immune related genes SMAD3, ZC3H12A, 
LY6G6E and the oncogene TFAP2E.  
The magnitude and direction of DNAm varied between and within genes, with multiple 
differentially methylated CpGs identified for most gene loci, supporting a biological role for 
these changes. In addition, pyrosequencing validation revealed additional neighbouring CpG 
sites with differential methylation for the genes studied, demonstrating a widespread effect 
of preterm birth at these loci. The majority of DNAm variation in protein-coding genes was 
identified in promoter regions (n=58) compared to the gene body (n=25) however, for some 
genes differential methylation also extended across both regions (n=11).  In mammals, the 
majority of methylation occurs in a CpG context, with clusters of CpGs known as CpG islands 
often associated with transcriptional start sites (TSS) or gene promoter regions. Methylation 
at these regions is negatively correlated with gene expression (Moore LD et al, 2013 & Jones 
PA, 2012). In contrast, methylation of CpGs within the gene body, the region that extends 
past the first exon, can be associated with increased gene expression (Moore LD et al, 2013).  
Therefore, the significant difference I have observed in DNAm between preterm and term 
infants in identified neural gene loci may translate to differential gene expression and 
contribute to the preterm neurological phenotype.  
This neurological phenotype as illustrated by pathological examination, structural MRI, 
diffusion MRI and volumetric studies includes a spectrum of change with disruption to 
myelination and white matter structural maturation, loss of grey and white matter volume, 
diffuse and cystic periventricular leukomalacia, neuronal loss and axonal degeneration (Back 
SA, 2014).  
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The functional profiles of the 10 neural genes include roles in neurological processes which 
may be involved in the pathogenesis of this preterm phenotype and in particular the 
pathogenesis of altered white matter integrity as summarised by Khwaja O and Volpe JJ, 2008. 
Their roles include the regulation of excitotoxic neurotransmitters, transport across the 
blood-brain-barrier, neuronal and glial signalling and involvement in memory, mood and 
social behaviour. Their candidacy is strengthened further by an association with neurological 
disease for the majority identified.   
A large number of CpGs in 2 members of the solute carrier membrane transporter proteins, 
SLC7a5 and SLC1a2 were identified as differentially methylated in preterm infants. SLC7a5, 
also known as LAT1, is a large amino acid (including L-glutamine, methionine and tryptophan) 
transporter, which is expressed abundantly at the blood-brain barrier (O’Kane RL et al, 2003). 
L-glutamine is the main precursor for excitatory (L-glutamate) and inhibitory (GABA) 
neurotransmitters, and alterations in its levels are implicated in ischemic brain injury, epilepsy 
and huntington disease (Dolgodilina E et al, 2016). In addition, subunits of GABA receptors 
are differentially expressed during oligodendrocyte development, and use of the selective 
agonist baclofen increases proliferation of oligodendrocyte precursor cells (Luyt K et al, 2007) 
demonstrating its involvement in early neuronal development. Methionine is a key 
component of S-adeosylmethionine (SAM), the major methyl donor required by cellular 
methyltransferases for DNAm, therefore LAT1 has recently been implicated in regulation of 
the epigenome indirectly by this cellular delivery pathway (Dann SG et al, 2015). Tryptophan 
crosses the blood-brain barrier to participate in the synthesis of serotonin, which has a well-
documented role in mood disorders such as Depression; stress responses and addiction 
behaviour (O’Mahony SM et al, 2015). Tryptophan is also metabolised via the kynurenine 
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pathway to quinolinic acid, a potent NMDA receptor which causes neuronal death and 
dysfunction (Rahman A et al, 2009). SLC7a5/ LAT-1 expression is affected by inflammation, 
with mRNA levels being reduced by the administration of LPS (Wittmann G et al, 2015), which 
implicates a possible pathway for inflammation/infection, excitoxicity and alteration to the 
white matter.  
SLC1a2 (also known as EAAT2, GLT-1) is a sodium dependent glutamate transporter, which is 
expressed on astrocytes, oligodendrocytes, macrophages and neurons during both 
development and in the adult nervous system (Desilva et al, 2007). There is good evidence 
that EAAT2 serves to clear glutamate from the extracellular space therefore limiting its 
excitotoxic effect (Maragakis NJ, Rothstein JD 2004). Variation in its expression is associated 
with neurodegenerative diseases such as ALS (amyotrophic lateral sclerosis), Alzheimer’s 
disease, Huntingdon disease and tuberous sclerosis (Sheldon AL et al, 2007) and neurological 
disorders including schizophrenia and bipolar bisorder (Shao L et al, 2008).  However, EAAT2 
appears to be developmentally regulated with increased expression observed between 24 to 
32 weeks (the peak period for PVL) and upregulation in the astrocytes of infants with PVL 
compared to controls (Desilva TM et al, 2007 & 2008). A recent study investigating 2 SNPs (g.-
200C>A and g.-181A>C) at EAAT2 has shown that the A allele at both loci is associated with 
increased risk of a low developmental score or cerebral palsy in preterm infants and 
alterations in EAAT2 promotor activity in vitro (Rajatileka S et al, 2017). In line with this, 
previous work revealed that replacement of the A allele to a C allele creates a binding site for 
GC binding factor 2 which represses EAAT2 expression and reduced glutamate uptake 
(Mallolas J et al, 2006) and infants with three C alleles have better outcomes than those with 
just one (Rajatileka S et al, 2017).  
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Whilst these findings initially seem conflicting in the context of preterm white matter injury, 
in vitro work with oligodendrocyte cultures demonstrate that ischaemia causes EAAT2 to 
operate in reverse with release of glutamate (Fern R & Möller T, 2000) and a EAAT2 knockout 
study has shown that although mutant mice have increased levels of glutamate in response 
to acute ischaemia, they have reduced levels in prolonged ischaemia (Mitani A, Tanaka K 
2003). Therefore, the function of EAAT2 might change from a neuroprotective role to 
detrimental role in the face of ischaemia and the ability to down regulate EAAT2 expression 
in developing white matter may be beneficial.   
Two other neural genes associated with excitotoxic processes showed differential DNAm 
between preterm and term populations, QPRT and GRIK5. QPRT or quinolinate 
phosphoribosyl transferase, catabolises quinolinate (quinolinic acid) which is, as discussed, a 
potent NMDA receptor agonist and considered neurotoxic (Rahman A et al, 2009). Elevated 
levels of quinolinate within brain tissue are associated with Alzheimer’s disease (Rahman A et 
al, 2009) and epilepsy (Feldblum S et al, 1988); and elevated levels in the CSF occur with 
neuroinflammatory disorders such as meningitis (Heyes MP et al, 1992). GRIK5, Glutamate 
receptor, ionotropic, kainate 5, also known as KA2, is a receptor for the excitotoxic 
neurotransmitter glutamate, which shows specific regional distribution in human 
hippocampus, neocortex and cerebellum (Porter RH et al, 1997) and has evidence for 
developmental regulation in animal studies (Ripellinoa JA et al, 1997). Variation in its 
expression is associated with schizophrenia (Porter RH et al, 1997 and Meador-Woodruff JH 
et al, 2001).  
APOL1, apolipoprotein L 1, is a secreted high-density lipoprotein with a role in lipid 
metabolism. It contains the Bcl-2 homology domain 3, a characteristic of proteins with a role 
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in cellular death, and accordingly overexpression and intracellular accumulation of APOL1 
promotes autophagic cell death (AuCD) (Wan G et al, 2008). Its overexpression in the brains 
of schizophrenics (Mimmack ML et al, 2002) suggests it may also regulate AuCD in the central 
nervous system. Furthermore, it is inducible by the inflammatory cytokines IF-gamma and 
TNF-alpha (Zhaorigetu S et al, 2008), which like LAT1 suggests a pathway that links perinatal 
infection, inflammation and preterm brain injury.  
The expression of LRG1, Leucine-rich alpha-2-glycoprotein 1, is also inducible by the 
inflammatory mediators IL-6, TNF alpha and IL-1 beta and administration of LPS (Shirai R et 
al, 2009). LRG1 is expressed in astrocytes and the cerebral cortex (Nakajima M et al, 2012) 
and increased levels in CSF are associated with ageing, Alzheimer’s disease and Parkinson’s 
disease dementia (Miyajima M et al, 2013).  LRG1 has the same LRR structure as another 
member of the LRR super-family LRRK2, which has a role in brain microglial activation (Moehle 
MS et al, 2012) and therefore it is possible that LRG1 activation may mediate 
neurodegenerative effects via microglia, which have a well-documented role in 
periventricular leukomalacia (Volpe JJ, 2011).   
Another of the neural genes which has a significant association with brain microglia is TREM2. 
Known in full as Triggering receptor expressed on myeloid cells 2, it is a member of the 
immunoglobulin superfamily which in the brain is mostly found within microglia, but 
expression on neurons and oligodendrocytes has also been reported (Lue LF et al, 2015). It is 
developmentally regulated, with decreasing levels in white matter structures found in 
postnatal mice brains (Chertoff M et al, 2013) but increasing expression observed with 
advancing age in human brain tissue (Forabosco P et al, 2013) with highest levels found in the 
white matter (Guerreiro R et al, 2013). Missense mutations at TREM2 have been associated 
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with Alzheimer’s disease, ALS, Parkinson’s disease and polycystic lipomembranous 
osteodysplasia with sclerosing leukoencephalopathy (PLOSL) a disease which causes severe 
bone cysts and pre-senile dementia (Klunemann HH et al, 2005 & Lue LF et al, 2015). From 
research characterising the role of TREM2 in these pathological processes, it has been shown 
that it TREM2 mediates the phagocytotic activity of microglia and regulates their pro-
inflammatory responses to Toll-like receptor-mediated cytokines (Lue LF et al 2015 & 
Hickman SE et al, 2014).  
The other identified neural genes (PRPH, NPBWR1 and MCHR1) do not currently have 
evidence in the literature in areas which may be linked directly to the pathogenesis of preterm 
white matter injury, however they do have significant roles in neuronal development and 
behaviours which can be related to the preterm population. PRPH encodes for peripherin, an 
intermediate filament protein that is mostly confined to the peripheral nervous system in 
adults, but has a variable pattern during embryonic development, with expression in a variety 
of neurons. It appears to have a role in neurite development and stability, with elevated levels 
found after neuronal injury (Zhao J et al, 2016) and variations in gene expression being 
associated with susceptibility to amyotrophic lateral sclerosis (Corrado L et al, 2011 and Gros-
Louis F et al, 2004). There are 2 neural genes which have behavioural roles identified from 
knockout studies in mice, NPBWR1 and MCHR1. NPWR1 is a G protein linked receptor for 
neuropeptides W and R, and is also known as GPR7. There is good evidence for its involvement 
in regulation of anxiety, stress and emotional responses with discrete expression seen in the 
hypothalamus, hippocampus, ventral tegmental area (VTA), and amygdala (Sakurai T, 2013). 
NPBWR1-/- mice have altered social responses, with increased impulsive behaviour, contact 
and chase time when presented with an intruder mouse (Nagata-Kuroiwa R et al, 2011). In 
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addition, it has a role in energy homeostasis with GPR7-/- mice developing hyperphagia and 
obesity (Ishii M et al, 2003). MCHR1 (Melanin-concentrating hormone receptor 1) has similar 
roles in the regulation of body weight, energy expenditure and hyperactivity as demonstrated 
by the behaviour of MCHR1 -/- mice (Marsh DJ et al, 2002) and DNAm at MCHR1 is correlated 
with BMI (Stepanow S et al, 2011).  
Principle component analysis was used to investigate the effect of diffusion MRI measures 
within 8 major white matter fasciculi and clinical neuroprotective and risk factors on DNA 
methylation within the preterm group. These parameters were chosen as there is good 
evidence in the literature that changes in FA, MD and R of the white matter is associated with 
preterm birth (Pandit AS et al, 2013 & Anblagan D et al, 2015) and the clinical risk and 
resilience factors were equally chosen for their well-documented effects on preterm clinical 
outcomes (Stoll BJ et al, 2002, Doyle LW et al, 2009, Schlapbach LJ et al, 2010, Ehrenkranz RA 
2010, van Kooij BJ et al, 2011 & Sotiriadis A et al, 2015).   
Initial analysis showed that the clinical factors of gender, exposure to chorioamnionitis and 
duration of TPN and the imaging parameters of FA in the corpus callosum and shape (R) of 
the right corticospinal tract contributed significantly to DNAm variation. After exclusion of 
CpG probes found on sex chromosomes, and a correction for multiple testing, three 
associations remained - shape (R) of the right corticospinal tract; and gender in combination 
with duration of TPN. However, when directly tested against the specific DMRs, none of these 
three variables showed a significant effect. This suggests that if there is an effect from these 
variables, it is subtle and distributed across many loci.  
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A summary of the functions of the immune related genes and promoters which have 
differential DNAm between preterm and control infants is given in tables 5.3a and 5.3b. The 
products of these genes include interferons, chemokines and other signalling molecules, 
proteins involved in both innate and adaptive immunity and inflammatory response 
regulators. The transfer of maternal antigen specific IgG is limited until after 32 weeks’ 
gestation, therefore preterm infants are deficient in immunoglobulins. There is also a positive 
correlation between gestational age and levels of antimicrobial proteins and peptides (APPs) 
which are released from leukocytes, as well as reduced levels of complement proteins and 
granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-
stimulating factor (GM-CSF) levels which lead to reduced circulating neutrophils and 
monocytes in preterm infants (Strunk T et al, 2011 & Melville JM et al, 2013). Relative to 
adults, all newborn infants have a reduced capacity for adaptive immunity (Melville JM et al, 
2013), however preterm infants also have reduced levels of IFN-γ and TFN- α compared to 
term infants (Hartel C et al, 2005). This impairment to the innate and adaptive immune system 
in combination with clinical factors such the disruption of the skin barrier by invasive tests, 
indwelling catheters, the need for parenteral nutrition and mechanical ventilation leave the 
preterm infant exquisitely susceptible to infection.  Around 20% of preterm infants will 
develop an episode of sepsis, and these infants have increased rates of mortality (Stoll BJ et 
al, 2002) and morbidity with increased risk of adverse neurodevelopmental outcomes 
including cerebral palsy (Stoll BJ et al, 2004). Although much of this immune function research 
is gestation specific, the results show that there are ongoing significant differences within key 
immune function genes at term equivalent age. In keeping with this, epidemiological studies 
have shown that preterm infants remain susceptible to infection after discharge from the 
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neonatal unit with increased ORs relating to respiratory infection and bacterial infections 
compared to infants born at term (Ray KN et al, 2013).  
Genes with oncogenic associations which showed differential DNAm between the preterm 
and term population are also shown in tables 5.3.a and 5.3.b. With regards to perinatal risk 
factors, another study has shown that DNAm is altered in PLAGL1, a gene which is important 
for tumour development and growth, in infants exposed to chorioamnionitis (Liu Y et al, 2013) 
and a recent epigenome-wide study (Cruickshank MN et al, 2014) has shown that in keeping 
with my data, preterm birth is associated with differential DNAm in 18-year old individuals in 
SMAD3, which is involved in tumour cell proliferation (Daly AC et al, 2010) and TFAP2E, which 
confers risk for colorectal cancer (Zhang ZM et al, 2014). These findings show that preterm 
birth may have a lasting legacy, not only in terms of neurodevelopment but also by increasing 
the susceptibility to infections and later life diseases such as cancer, and that this may be 
mediated by alterations in the methylome.  
The approaches I utilised in this study which may have impacted data include tissue type, the 
timing of sampling and the method of assessing DNAm. My approach used bisulphite 
conversion, which converts unmethylated 5-methylcytosines (5mC) to uracil, thus allowing 
thymine amplification during PCR and subsequent identification by the Illumina Methylation 
array. An inherent problem with this approach is that it does not differentiate between 5mC 
and 5-hydroxymethylcytosine (Jones PA, 2012), which may have different distributions and 
functions within the epigenome (Branco MR et al, 2012). The bioinformatics post-processing 
of the results, with removal of methylation at non-CpG sites helps to reduce some of this 
confounding data.  
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I chose to sample the population at term equivalent age, which allowed me to examine the 
allostatic load of preterm birth and its clinical sequelae. However, this approach may miss 
temporal cues for epigenetic modification throughout the perinatal period and indeed 
beyond. Two recent studies have demonstrated the dynamic nature of DNAm, with variations 
observed between preterm and term cohorts, which were significant at birth, or term 
corrected age, resolving by 1 year (Piyasena C et al, 2016) and 18 years of age (Cruickshank 
MN et al, 2014). Additionally, other studies have used other tissues types such as umbilical 
blood for analysis and this may account for the differences in loci I have identified compared 
to other groups (Fernando F et al, 2015). I used saliva samples for epigenetic tissue sampling 
due to its acceptable, non-invasive nature and the evidence that shows that DNAm from saliva 
shows better correlation with post-mortem brain tissue than blood (Smith AK et al, 2015). 
Therefore, in order to fully investigate the effect of preterm birth on the epigenome, a 
multiple sampling study which included maternal samples, placenta, cord blood and saliva 
from infants at birth and across their life-course would be required.  
5.5 Conclusions  
In conclusion, this chapter shows that the stress of preterm birth is associated with 
differential methylation in several protein-coding genes. These data include several promising 
neural candidate genes which could be involved in the pathogenesis of preterm white matter 
injury, neurodevelopmental and neuropsychiatric disorders. There are also a significant 
number of genes with involvement in immune function and oncogenic potential, 
demonstrating a mechanism for the link between early life stress and later life disease. The 
methylation array data was validated successfully using pyrosequencing.  
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By use of PNT to assess white matter integrity and principle component analysis, I was able 
to determine that there is an association between preterm neurological phenotype and the 
methylome which is modifiable by gender and early life nutritional factors. In this group, the 
association was subtle and therefore future work is required with more subjects. Future work 
should include a multiple sampling technique with assessment of the methylome at 








Chapter 6: Discussion 
6.1 Findings  
I have demonstrated within this cohort of preterm infants at term, and with term controls, that 
preterm birth is associated with significant alterations to white matter integrity. Preterm infants 
with exposure to neuroprotective agents including antenatal steroids and magnesium sulphate 
have a quantifiable increase in white matter maturity in select regions, whilst those experiencing 
an episode of sepsis have a reduction.  
The ROI approach used in this analysis was compared to a tract averaged technique and found to 
produce DTI parameters with limited agreement. The ROI approach may not be representative 
of the microstructural integrity of an entire white matter tract and can be subjective in nature. 
Therefore, a more objective method such as PNT may be preferable for assessing white matter 
integrity in an image linked epigenetic study.  
From analysis of the entire methylome at term corrected age, I have shown that prematurity is 
associated with differential methylation in protein-coding genes with an identified role in 
neurological disease and neurodevelopment. In particular, there are several genes which can be 
linked to the pathogenic processes involved in white matter injury. There are also a significant 
number of genes with involvement in immune function and oncogenic potential, demonstrating 
a mechanism for the link between early life stress and later life disease. The methylation array 
data was validated successfully using pyrosequencing.  
By use of PNT to assess white matter integrity and principle component analysis, I was able to 
determine that there is an association between preterm neurological phenotype and the 
methylome, which is modifiable by gender and early life nutritional factors.  
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6.2 Limitations  
In chapter 3, 99 preterm and 26 term infants were recruited. However, 23 preterm and 7 term 
infants were lost post-consent for reasons that included a subsequent genetic diagnosis of Down 
Syndrome (n=1), and a further identification of PVL on structural MRI (n=1). Chromosomal 
abnormalities may lead to significant differences in DNA methylation as evidenced by recent 
investigation of the methylome in adults with Down syndrome, compared to control subjects 
(Jones MJ et al, 2013) and therefore this exclusion was important to ensure representative DNAm 
results. The loss of other subjects to illness (n =6) may have been prevented by seeking consent 
closer to term corrected age, thus identifying those who were unable to fulfil the inclusion 
criteria. Despite a protocol which included imaging infants in natural sleep with the aid of 
swaddling and suction molded head restraint, 12 infants were too unsettled for full DTI data 
capture (9.6%). Movement artefact also limited analysis in chapter 4 as 14 subjects (15%) from 
the 95 with DTI imaging were found to be unsuitable for PNT analysis due to difficulties in tract 
segmentation. As discussed, other groups have used sedation within their protocols (Counsell SJ 
et al, 2008 & Boardman JP et al, 2010) and this may have reduced post consent exclusion. A post-
analysis correction was required between the preterm and term infants due to significant 
differences in PMA at time of scan and FA and MD have been shown to change rapidly during 
perinatal brain development (Huppi PS et al, 1998). Antenatal consent of term infants may have 
allowed the logistical organization of a cohort that was more closely matched in PMA at time of 
scan.  
The exclusion of infants with haemorrhagic parenchymal infarction (HPI) and cystic PVL was 
considered valid, as these represent the minority of neonatal patients, which may have skewed 
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the results. Furthermore, in the case of severe injury, it may have been difficult to identify the 
correct regions for accurate placement of the ROI in DTI analysis. However, this subgroup is 
important, and indeed may benefit the most from research which includes protective strategies. 
Therefore, future work may include these patients, with a strategy that involves a separate 
subgroup analysis.  
My results demonstrated alterations in white matter integrity after exposure to antenatal 
magnesium sulphate, corticosteroids and post-natal sepsis, however not all white matter regions 
were similarly affected and risk factors such as BPD, male gender and chorioamnionitis were not 
associated with any significant alteration. Power calculations were not possible for this study and 
therefore subject numbers were taken from precedent in the literature. I may have observed an 
effect with BPD, male gender or BPD in a larger cohort study. In addition, as concluded in chapter 
3, ROI analysis may not offer the most complete representation of the preterm neurological 
phenotype and other methods such as TBSS, PNT or connectivity studies may offer additional 
information.  
In chapter 4 I demonstrated that, in line with other ROI reliability studies (Lepomaki et al, 2012), 
the intra-observer agreement of FA and MD values produced by manual ROI placement in the 
gCC and PLIC was high. However, other groups have shown that inter-rater ROI analysis may be 
reduced to a 1/3rd of intra-user (Muller et al, 2006 & Ciccarelli et al, 2003). The evaluation of ROI 
methodology in this patient group could be improved by conducting inter-rater analysis and 
including other defined white matter areas such as the anterior limb of the internal capsule.  
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Our population of 36 preterm infants at TEA and 36 sex-matched term controls in chapter 5, were 
determined given patient numbers in other early life stress epigenome-wide human studies 
(Cruickshank MN et al, 2013; Labonte B et al, 2012; Khulan B et al, 2014). Due to time and 
logistical constraints, not all term infants had image-linked data available, which would be 
preferable for ongoing work.  
The population studied in chapter 5, was predominantly of white British ethnic origin (94% term, 
86% preterm). Recent studies have demonstrated that up to 75% of variation in DNA methylation 
between subgroups of subjects can be explained by genetic ancestry (Galanter JM et al, 2017). 
Therefore, although this is beneficial in that the differences observed in DNA methylation may 
not be significantly affected by ethnicity, it does mean that our results could vary significantly 
from patient groups found in other regions where there is more diversity.  
Given the large quantity of data produced by the methylation array (>485,000 CpG probes), a 
bioinformatics expert was employed to process the data and run the statistical analysis. Analysis 
of this volume of data is subject to bias from sample processing and confounding experimental 
variables such as batch processing (Wright ML et al, 2016). Therefore, pre-processing and 
normalization stages were required to improve validity of the resulting data. Samples were 
filtered to ensure that they were of adequate quality using a control probe technique. A probe 
filtering step was used to remove unreliable or non-specific probes or those which overlapped 
with SNPs. The Illumina array has negative control probes, which allow for background intensity 
calculations. If a probe does not have a differential DNAm with p value of >0.01 compared to the 
negative control probes, it can be considered unreliable and therefore removed. SNPs are also 
removed as they can affect probe binding at the CpG site, lowering the signal artificially. 
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Normalisation of the data, allowed the true intensity signals to be analysed over any background 
artifact or ‘noise’. It also allowed for harmonization of the differences in methylation discovered 
by the 2 probe types used in the assay (type I and type II probes). Finally, batch corrections were 
completed to account for any differences occurring from processing samples on different days, 
which was particularly relevant given that 12 samples were processed as part of an initial pilot 
study. From the 25 protein coding gene bodies and 58 protein coding gene promoters which 
showed differential DNAm in preterm infants compared to controls, 10 neural genes were 
identified using strict literature search criteria. This method is reliant on available literature and 
therefore future work may implicate other genes in neurological processes or disease. Principle 
component analysis enabled evaluation of the impact of clinical risk factors and the preterm 
neural phenotype (as determined by white matter integrity) on DNAm.  However, after post-
filtering and correction for multiple testing, only shape (R) of the right corticospinal tract and 
gender, in combination with duration of TPN, remained significantly associated with DNAm. 
Furthermore, no variable showed a significant effect when directly tested against the specific 
DMRs. This suggests that if there is an effect from these variables, it is subtle and distributed 
across many loci. As discussed in chapter 5, the choice of tissue type and time of sampling may 
alter results from both the methylation array and subsequent PCA analysis. In addition, increased 








6.3 Future Directions 
This thesis has generated several questions for future investigation, including further evaluation 
of clinical risk factors such as inflammation, the effect of early-life stress on the epigenome and 
the impact of neuroprotective interventions on the preterm neurological phenotype.  
Firstly, given my results which show that late-onset sepsis is associated with reduced white 
matter integrity in preterm infants at TEA, I would like to further investigate the impact of other 
inflammatory processes including chorioamnionitis, early-onset infection and late-onset-sepsis 
on the preterm neurological phenotype. I would complete DTI analysis using a tract-based 
technique (PNT) on preterm infants (<1500 grams or 32 weeks’ gestation) at various 
developmental time-points including, within the first week of life, at term corrected age and at 2 
years of age.  I would include 8 major white matter fasciculi (genu and splenium of corpus 
callosum, left and right cingulum cingulate gyrus, left and right corticospinal tracts (CST) and left 
and right inferior longitudinal fasciculi). I would define infection as blood culture positive sepsis 
with signs of clinical instability and ensure chorioamnionitis was histologically defined. I would 
collect data on serum inflammatory markers including white blood cell count, platelets and CRP. 
I would also collect CSF in order to evaluate white cell count and presence of bacteria to identify 
meningitis or CNS infection. CSF could also be analysed for quinolinate which has been shown to 
be elevated in meningitis (Heyes MP et al, 1992) and in other neurological diseases such as 
Alzheimer’s (Rahman A et al, 2009) and epilepsy (Feldblum S et al, 1988) as well as showing 
differential DNAm at QPRT (the enzyme which catabolises quinolinate) between preterm infants 
at TEA and term controls in my own work. As the collection of CSF is an invasive test, it may be 
limited to infants who are undergoing a lumbar puncture for suspected sepsis. Therefore, the 
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tissue specific effect of DNAm at QPRT and levels of quinolinate could be further investigated by 
employing an animal model of inflammation, by serum administration of LPS (lipopolysaccharide) 
(Silbereis JC et al, 2010). This temporal approach, as well as the investigation of a novel 
inflammatory marker such as quinolinate may allow early identification of those preterm infants 
at risk.  
Secondly, as I have shown that preterm birth is associated with epigenetic changes at term 
equivalent age, I would like to investigate this in more detail with a candidate gene approach. Of 
particular interest is SLC1a2 (also known as EAAT2 or GLT-1). In my work, there is a reduction in 
DNAm at SLC1a2 (EAAT2) in preterm infants compared to term at TEA. Previous work has 
demonstrated that down-regulation of EAAT2 may be advantageous to neurodevelopment, 
particularly in the context of preterm white matter injury (Desilva TM et al, 2007 & 2008, 
Rajatileka S et al, 2017). In order to further investigate the effect of DNAm at SLC1a2 in relation 
to white matter injury, I would employ a multiple sampling approach with maternal samples, 
placenta, cord blood and saliva from preterm infants at birth, at TEA and 2 years of age. I would 
compare DNAm at SLC1a2 with white matter changes on DTI, using a tract based approach (PNT) 
in the 8 white matter regions mentioned above. I would include infants with PVL identified using 
cranial ultrasound screening.  In order to investigate tissue specific DNAm of SLC1a2 and protein 
synthesis, an animal model of diffuse WMI (maternal sheep hypoxemia at 65% of gestation) could 
be utilized (Silbereis JC et al, 2010). This work would provide more information on the inheritance 
of DNAm at SLC1a2, its variation over time, how it relates to protein synthesis, its effect on the 
preterm neurological phenotype and its relation to PVL.   
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Finally, my work has demonstrated that antenatal administration of magnesium sulphate is 
associated with improved white matter integrity in select white matter regions in preterm infants 
at term equivalent age. Magnesium sulphate may partly exert a neuroprotective effect by 
effecting BBB permeability (Esen F et al, 2005; Euser AG et al, 2008), which renders the embryonic 
and newborn brain more vulnerable to circulating drugs and toxins than the adult brain (Saunders 
NR et al, 2012). Therefore, the effect of antenatal MgSO4 treatment could be more thoroughly 
investigated by dynamic contrast enhanced MRI (DCE-MRI), a technique for studying BBB 
disruption in vivo (Heye AK et al, 2014). It involves introduction of a low molecular weight 
contrast agent, usually a Gadolinium (III)-based (Yan Y et al, 2017).  Although these agents have 
been approved for clinical trials, they may not be acceptable for neonatal subjects. Therefore, an animal 
model of prematurity (Elovitz MA, 2004) could be used to assess BBB permeability in subjects 
who had been exposed to antenatal MgSO4 compared to those who had not. It would also be 
interesting to replicate HCA or LOS as inflammation is also known to disrupt the BBB (Saunders 
NR et al, 2012) with the administration of LPS.  
These future experiments, would allow a more comprehensive analysis of some of the risk and 
resilience factors associated with preterm white matter injury, and may lead to earlier 
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